Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 52
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

New Mutations in ADC-Type β-Lactamases From Acinetobacter Spp. Affect Cefoxitin and Ceftazidime Hydrolysis

  • Pérez, Astrid
  • Pérez-Llarena, Francisco J.
  • García, Patricia
  • Kerff, Frédéric
  • Beceiro Casas, Alejandro
  • Galleni, Moreno
  • Bou, Germán
This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Journal of Antimicrobial Chemotherapy following peer review. The version of record is available online at: https://doi.org/10.1093/JAC/DKU163., [Abstract] Objectives: Two natural variants of ADC-type β-lactamases of Acinetobacter spp., ADC-1 and ADC-5, differ by nine mutations in their protein sequence. ADC-5 hydrolyses cefoxitin better than ADC-1 and the opposite is true for ceftazidime. We produced single and combined mutations in ADC-5 and characterized the variants microbiologically and biochemically to determine which amino acid residues are involved in the hydrolysis of β-lactam antibiotics in this family of β-lactamases. Methods: Site-directed mutagenesis, with blaADC-5 as a source of DNA, was used to generate nine single mutated and three combined mutated enzymes. The proteins (wild-type and derivatives) were then expressed in isogenic conditions in Escherichia coli. MICs of β-lactams were determined using Etest strips. ADC-1, ADC-5, ADC-5-P167S and ADC-5-P167S/D242G/Q163K/G342R were also purified and the kinetic parameters determined for ceftazidime, cefoxitin, cefalotin and ampicillin. Results: Single mutations did not significantly convert the hydrolysis spectrum of the ADC-5 enzyme into that of the ADC-1 enzyme, although among all studied mutants only the quadruple mutant (ADC-5-P167S/D242G/Q163K/G342R) displayed microbiological and biochemical properties consistent with those of ADC-1. Conclusions: Although some single mutations are known to affect cefepime hydrolysis in ADC-type β-lactamases, little is known about ceftazidime and cefoxitin hydrolysis in this family of β-lactamases. Hydrolysis of these antibiotics appears to be positively and negatively affected, respectively, by the Q163K, P167S, D242G and G342R amino acid replacements., This study was funded by grants from the European Community, FP7, ID: 278232 (MagicBullet), and by Plan Nacional de I+D+I 2008–2011 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), cofinanced by the European Development Regional Fund (EDRF) ‘A Way to Achieve Europe’. It has also been funded by the Fondo de Investigación Sanitaria (grant PI12/00552). F. K. is a research associate of the FRS-FNRS (Brussels, Belgium)
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain

  • Fernández-Martínez, Marta
  • Miró, Elisenda
  • Ortega, Adriana
  • Bou, Germán
  • González-López, Juan José
  • Oliver, Antonio
  • Pascual, Álvaro
  • Cercenado, Emilia
  • Oteo, Jesús
  • Martínez-Martínez, Luis
  • Navarro, Ferrán
Multicenter study, [Abstract] The activity of eight aminoglycosides (amikacin, apramycin, arbekacin, gentamicin, kanamycin, neomycin, netilmicin and tobramycin) against a collection of 257 amoxicillin/clavulanic acid (AMC)-resistant Escherichia coli isolates was determined by microdilution. Aminoglycoside resistance rates, the prevalence of aminoglycoside-modifying enzyme (AME) genes, the relationship between AME gene detection and resistance phenotype to aminoglycosides, and the association of AME genes with mechanisms of AMC resistance in E. coli isolates in Spain were investigated. Aminoglycoside-resistant isolates were screened for the presence of genes encoding common AMEs [aac(3)-Ia, aac(3)-IIa, aac(3)-IVa, aac(6')-Ib, ant(2″)-Ia, ant(4')-IIa and aph(3')-Ia] or 16S rRNA methylases (armA, rmtB, rmtC and npmA). In total, 105 isolates (40.9%) were resistant to at least one of the aminoglycosides tested. Amikacin, apramycin and arbekacin showed better activity, with MIC90 values of 2mg/L (arbekacin) and 8mg/L (amikacin and apramycin). Kanamycin presented the highest MIC90 (128mg/L). The most common AME gene was aac(6')-Ib (36 strains; 34.3%), followed by aph(3')-Ia (31 strains; 29.5%), ant(2″)-Ia (29 strains; 27.6%) and aac(3)-IIa (23 strains; 21.9%). aac(3)-Ia, aac(3)-IVa, ant(4')-IIa and the four methylases were not detected. The ant(2″)-Ia gene was usually associated with OXA-1 [21/30; 70%], whilst 23/25 (92%) strains producing CTX-M-15 had the aac(6')-Ib gene. The most prevalent AME gene was aac(6')-Ib (18/41; 44%) in nosocomial isolates, whilst ant(2″)-Ia and aph(3')-Ia genes (20/64; 31%) were more frequent in strains of community origin. In 64.6% isolates the phenotypic profile correlated with the presence of commonly encountered AMEs., This study was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, co-financed by the European Development Regional Fund, A Way To Achieve Europe, ERDF; the Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015]; and the Fondo de Investigación Sanitaria [grants PI12/00552, PI11/1117 and PI09/917].
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

  • Fernández-Cuenca, Felipe
  • Tomás, María
  • Caballero-Moyano, Francisco-Javier
  • Bou, Germán
  • Martínez-Martínez, Luis
  • Vila, Jordi
  • Pachón, Jerónimo
  • Cisneros, José Miguel
  • Rodríguez-Baño, Jesús
  • Pascual, Álvaro
Multicenter study, [Abstract] Objectives: The objective of this study was to analyse whether there is an association between reduced susceptibility to biocides in Acinetobacter baumannii and (i) antimicrobial resistance (co-resistance), (ii) prevalent (epidemic) clones, (iii) changes in the fitness or (iv) expression of genes related to efflux pumps and porins. Methods: Susceptibility to biocides and antimicrobials was determined in 49 clonally unrelated isolates of A. baumannii. Biological cost, in terms of mean generation time, was determined by spectrophotometry. Quantitative real-time RT-PCR was used to determine the relative expression of genes encoding several efflux pumps and porins. Results: Reduced susceptibility to chlorhexidine digluconate, benzalkonium chloride and Irgasan(®) was associated with resistance to aminoglycosides, tetracycline and ciprofloxacin (P < 0.05). The MICs of carbapenems, aminoglycosides, doxycycline and ciprofloxacin for isolate Ab70 (epidemic clone) exposed to these biocides increased by ≥2 dilutions. Reduced susceptibility to Orsan(®) was more frequent among prevalent clones than non-prevalent clones (P < 0.05). Mean generation times for Ab70 before and after exposure to benzalkonium chloride were 57.8 and 78.1 min, respectively (P = 0.02). Relative expression of abeS and adeB was increased in Ab46 and Ab70 after exposure to chlorhexidine digluconate, but was decreased for ompA and carO after exposure to Irgasan(®). Conclusions: Reduced susceptibility to biocides is associated with co-resistance to carbapenems, aminoglycosides, tetracycline and ciprofloxacin. Reduced susceptibility to Orsan(®) may be a marker of prevalent clones. Acquisition of reduced susceptibility to benzalkonium chloride has a biological cost. Exposure to biocides affects the relative expression of genes related to some efflux pump genes (increased expression) or porins (reduced expression)., This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (projects PI11-02046 and PI10/00056) and the Consejería de Innovación Ciencia y Empresa, Junta de Andalucía (P11-CTS-7730), Spain, by the Plan Nacional de I+D+i 2008-2011 and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem

  • Oteo, Jesús
  • Ortega, Adriana
  • Bartolomé, Rosa
  • Bou, Germán
  • Conejo, María del Carmen
  • Fernández-Martínez, Marta
  • González-López, Juan José
  • Martínez-García, Laura
  • Martínez-Martínez, Luis
  • Merino Carballeira, María
  • Miró, Elisenda
  • Mora-Rillo, Marta
  • Navarro, Ferrán
  • Oliver, Antonio
  • Pascual, Álvaro
  • Rodríguez-Baño, Jesús
  • Ruiz Carrascoso, Guillermo
  • Ruiz-Garbajosa, Patricia
  • Zamorano, Laura
  • Bautista, Verónica
  • Pérez-Vázquez, María
  • Campos, José
[Abstract] The aim of this study was to determine the impact of carbapenemase-producing Enterobacteriaceae (CPE) in Spain in 2013 by describing the prevalence, dissemination, and geographic distribution of CPE clones, and their population structure and antibiotic susceptibility. From February 2013 to May 2013, 83 hospitals (about 40,000 hospital beds) prospectively collected nonduplicate Enterobacteriaceae using the screening cutoff recommended by EUCAST. Carbapenemase characterization was performed by phenotypic methods and confirmed by PCR and sequencing. Multilocus sequencing types (MLST) were determined for Klebsiella pneumoniae and Escherichia coli. A total of 702 Enterobacteriaceae isolates met the inclusion criteria; 379 (54%) were CPE. OXA-48 (71.5%) and VIM-1 (25.3%) were the most frequent carbapenemases, and K. pneumoniae (74.4%), Enterobacter cloacae (10.3%), and E. coli (8.4%) were the species most affected. Susceptibility to colistin, amikacin, and meropenem was 95.5%, 81.3%, and 74.7%, respectively. The most prevalent sequence types (STs) were ST11 and ST405 for K. pneumoniae and ST131 for E. coli. Forty-five (54.1%) of the hospitals had at least one CPE case. For K. pneumoniae, ST11/OXA-48, ST15/OXA-48, ST405/OXA-48, and ST11/VIM-1 were detected in two or more Spanish provinces. ST11 isolates carried four carbapenemases (VIM-1, OXA-48, KPC-2, and OXA-245), but ST405 isolates carried OXA-48 only. A wide interregional spread of CPE in Spain was observed, mainly due to a few successful clones of OXA-48-producing K. pneumoniae (e.g., ST11 and ST405). The dissemination of OXA-48-producing E. coli is a new finding of public health concern. According to the susceptibilities determined in vitro, most of the CPE (94.5%) had three or more options for antibiotic treatment., This work was supported by a grant from the Fondo de Investigación Sanitaria (grant PI12/01242); the Antibiotic Resistance Surveillance Programme of the Spanish Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad; the Plan Nacional de I+D+I 2008–2011; and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), cofinanced by the European Development Regional Fund (ERDF) “A way to achieve Europe.”
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Rapid detection of enterobacteriaceae producing extended spectrum beta-lactamases directly from positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry

  • Oviaño, Marina
  • Fernández, Begoña
  • Barba, María José
  • Mouriño, C.
  • Bou, Germán
[Abstract] Bacteria that produce extended-spectrum β-lactamases (ESBLs) are an increasing healthcare problem and their rapid detection is a challenge that must be overcome in order to optimize antimicrobial treatment and patient care. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) has been used to determine resistance to β-lactams, including carbapenems in Enterobacteriaceae, but the methodology has not been fully validated as it remains time-consuming. We aimed to assess whether MALDI-TOF can be used to detect ESBL-producing Enterobacteriaceae from positive blood culture bottles in clinical practice. In the assay, 141 blood cultures were tested, 13 of them were real bacteraemias and 128 corresponded to blood culture bottles seeded with bacterial clinical isolates. Bacteraemias were analysed by MALDI-TOF after a positive growth result and the 128 remaining blood cultures 24 h after the bacterial seeding. β-lactamase activity was determined through the profile of peaks associated with the antibiotics cefotaxime and ceftazidime and its hydrolyzed forms. Clavulanic acid was added to rule out the presence of non-ESBL mechanisms. Overall data show a 99% (103 out of 104) sensitivity in detecting ESBL in positive blood cultures. Data were obtained in 90 min (maximum 150 min). The proposed methodology has a great impact on the early detection of ESBL-producing Enterobacteriaceae from positive blood cultures, being a rapid and efficient method and allowing early administration of an appropriate antibiotic therapy., This study was funded by grants from the European Community, FP 7, ID: 278232 (MagicBullet), and by Plan Nacional de I+D+I 2008-2011 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014) co-financed by European Development Regional Fund ‘A Way to achieve Europe’ ERDF, and by the Fondo de Investigación Sanitaria (grant PI12/00552).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Evaluation of MALDI-TOF mass spectrometry for identification of anaerobic bacteria

  • Barba, María José
  • Viña Fernández, Anabel María
  • Oviaño, Marina
  • Fernández, Begoña
  • Velasco, David
  • Bou, Germán
Comparative study, [Abstract] In this study MALDI-TOF MS was evaluated in the identification of anaerobic bacteria comparing it with Rapid ID 32A system. Discrepancies were solved by 16S r-RNA gene sequencing. At the species level MALDI-TOF MS identified 94.82% and Rapid ID 32A 86.67%, showing the superiority of MALDI-TOF MS to conventional methods., This study was funded by the European Community (FP 7, ID:278232, MagicBullet), and by Plan Nacional de I+D+I 2008–2011 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014)-co-financed by European Development Regional Fund “A Way to achieve Europe” ERDF and, finally by the Fondo de Investigación Sanitaria (grant PI12/00552).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Analysis of the Role of the LH92_11085 Gene of a Biofilm Hyper-Producing Acinetobacter baumannii Strain on Biofilm Formation and Attachment to Eukaryotic Cells

  • Álvarez-Fraga, Laura
  • Pérez Gómez, Astrid
  • Rumbo-Feal, Soraya
  • Merino Carballeira, María
  • Vallejo, J. A.
  • Ohneck, Emily J.
  • Edelmann, Richard E.
  • Beceiro Casas, Alejandro
  • Vázquez-Ucha, Juan Carlos
  • Valle, Jaione
  • Actis, Luis
  • Bou, Germán
  • Poza, Margarita
[Abstract] Acinetobacter baumannii is a nosocomial pathogen that has a considerable ability to survive in the hospital environment partly due to its capacity to form biofilms. The first step in the process of establishing an infection is adherence of the bacteria to target cells. Chaperone-usher pili assembly systems are involved in pilus biogenesis pathways that play an important role in adhesion to host cells and tissues as well as medically relevant surfaces. After screening a collection of strains, a biofilm hyper-producing A. baumannii strain (MAR002) was selected to describe potential targets involved in pathogenicity. MAR002 showed a remarkable ability to form biofilm and attach to A549 human alveolar epithelial cells. Analysis of MAR002 using transmission electron microscopy (TEM) showed a significant presence of pili on the bacterial surface. Putative protein-coding genes involved in pili formation were identified based on the newly sequenced genome of MAR002 strain (JRHB01000001/2 or NZ_JRHB01000001/2). As assessed by qRT-PCR, the gene LH92_11085, belonging to the operon LH92_11070-11085, is overexpressed (ca. 25-fold more) in biofilm-associated cells compared to exponential planktonic cells. In the present work we investigate the role of this gene on the MAR002 biofilm phenotype. Scanning electron microscopy (SEM) and biofilm assays showed that inactivation of LH92_11085 gene significantly reduced bacterial attachment to A549 cells and biofilm formation on plastic, respectively. TEM analysis of the LH92_11085 mutant showed the absence of long pili formations normally present in the wild-type. These observations indicate the potential role this LH92_11085 gene could play in the pathobiology of A baumannii., The results of this work have been funded by the Projects PI11/01034 to MP and PI14/00059 to MP and AB and PI12/00552 and PI15/00860 to GB, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 and funded by the ISCIII- General Subdirection of Assessment and Promotion of the Research – European Regional Development Fund (FEDER) “A way of making Europe” and Miami University (Ohio, USA) Research Funds. We also thank Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to GB), cofinanced by the European Development Regional Fund (EDRF) “A Way to Achieve Europe, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad. A.P. was financially supported by the Galician Plan for Research, Innovation and Growth (I2C Plan 2012-2016). J.A. Vallejo was financially supported by the Sara Borrell Program (ISCIII, Spain CD13/00373). We wish to thank grant GEIH/REIPI-Ab2010 from Instituto de Salud Carlos III - Ministerio Economía y Competitividad for providing MAR002 strain and M.I. Voskuil for pMo130.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Identification of a DNA-Damage-Inducible Regulon in Acinetobacter baumannii

  • Aranda Rodríguez, Jesús
  • Poza, Margarita
  • Shingu-Vázquez, Miguel
  • Cortés, Pilar
  • Boyce, John Dallas
  • Adler, Ben
  • Barbé, Jordi
  • Bou, Germán
[Abstract] The transcriptional response of Acinetobacter baumannii, a major cause of nosocomial infections, to the DNA-damaging agent mitomycin C (MMC) was studied using DNA microarray technology. Most of the 39 genes induced by MMC were related to either prophages or encoded proteins involved in DNA repair. Electrophoretic mobility shift assays demonstrated that the product of the A. baumannii MMC-inducible umuD gene (umuDAb) specifically binds to the palindromic sequence TTGAAAATGTAACTTTTTCAA present in its promoter region. Mutations in this palindromic region abolished UmuDAb protein binding. A comparison of the promoter regions of all MMC-induced genes identified four additional transcriptional units with similar palindromic sequences recognized and specifically bound by UmuDAb. Therefore, the UmuDAb regulon consists of at least eight genes encoding seven predicted error-prone DNA polymerase V components and DddR, a protein of unknown function. Expression of these genes was not induced in the MMC-treated recA mutant. Furthermore, inactivation of the umuDAb gene resulted in the deregulation of all DNA-damage-induced genes containing the described palindromic DNA motif. Together, these findings suggest that UmuDAb is a direct regulator of the DNA damage response in A. baumannii., This work was supported by the following: a grant from the Instituto de Salud Carlos III, Ministerio Economía y Competitividad No. Expediente PI11/01034 Unión Europea, Fondo Europeo de Desarrollo Regional, to M.P; by a grant from the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and Fondo de Investigaciones Sanitarias (PI081638 and PI12/00552) to G.B; and by grants BFU2011-23478 (from the MICINN) and 2009SGR1106 (from the Generalitat de Catalunya) to J.B. J.A. is the recipient of a Sara Borrell postdoctoral grant from the Instituto de Salud Carlos III (Madrid, Spain)., Generalitat de Catalunya; 2009SGR1106
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii

  • Martínez Guitián, Marta
  • Vázquez-Ucha, Juan Carlos
  • Odingo, Joshua
  • Parish, Tanya
  • Poza, Margarita
  • White, Richard D.
  • Bou, Germán
  • Wareham, David
  • Beceiro Casas, Alejandro
[Abstract] Synergy between colistin and the signal peptidase inhibitor MD3 was tested against isogenic mutants and clinical pairs of Acinetobacter baumannii isolates. Checkerboard assays and growth curves showed synergy against both colistin-susceptible strains (fractional inhibitory concentration index [FICindex] = 0.13 to 0.24) and colistin-resistant strains with mutations in pmrB and phosphoethanolamine modification of lipid A (FICindex = 0.14 to 0.25) but not against colistin-resistant Δlpx strains with loss of lipopolysaccharide (FICindex = 0.75 to 1). A colistin/MD3 combination would need to be targeted to strains with specific colistin resistance mechanisms., This work, including the efforts of German Bou, was funded by MINECO | Instituto de Salud Carlos III (ISCIII) (PI12/00552). This work, including the efforts of Margarita Poza and Alejandro Beceiro, was funded by MINECO | Instituto de Salud Carlos III (ISCIII) (PI14/00059). This work, including the efforts of Juan C. Vázquez-Ucha and Alejandro Beceiro, was funded by MINECO | Instituto de Salud Carlos III (ISCIII) (CP13/00226). This work was supported by the Spanish National Plans for Scientific Research, Development and Technological Innovation 2008-2011 and 2013-2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of the Research European Regional Development Fund (ERDF) “A way of making Europe” and also by the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii

  • Vázquez-Ucha, Juan Carlos
  • Maneiro Rey, María
  • Martínez Guitián, Marta
  • Buynak, John
  • Bethel, Christopher R.
  • Bonomo, Robert
  • Bou, Germán
  • Poza, Margarita
  • González-Bello, Concepción
  • Beceiro Casas, Alejandro
[Abstract] The number of infections caused by Gram-negative pathogens carrying carbapenemases is increasing, and the group of carbapenem-hydrolyzing class D β-lactamases (CHDLs) is especially problematic. Several clinically important CHDLs have been identified in Acinetobacter baumannii, including OXA-23, OXA-24/40, OXA-58, OXA-143, OXA-235, and the chromosomally encoded OXA-51. The selection and dissemination of carbapenem-resistant A. baumannii strains constitutes a serious global threat. Carbapenems have been successfully utilized as last-resort antibiotics for the treatment of multidrug-resistant A. baumannii infections. However, the spread of OXA carbapenemases is compromising the continued use of these antimicrobials. In response to this clinical issue, it is necessary and urgent to design and develop new specific inhibitors with efficacy against these enzymes. The aim of this work was to characterize the inhibitory activity of LN-1-255 (a 6-alkylidene-2-substituted penicillin sulfone) and compare it to that of two established inhibitors (avibactam and tazobactam) against the most relevant enzymes of each group of class D carbapenemases in A. baumannii. The β-lactamase inhibitor LN-1-255 demonstrated excellent microbiological synergy and inhibition kinetics parameters against all tested CHDLs and a significantly higher activity than tazobactam and avibactam. A combination of carbapenems and LN-1-255 was effective against A. baumannii class D carbapenemases. Docking assays confirmed the affinity of LN-1-255 for the active site of these enzymes. LN-1-255 represents a potential new β-lactamase inhibitor that may have a significant role in eradicating infections caused by A. baumannii isolates carrying CHDLs., This work was financially supported by Planes Nacionales de I+D+i 2008-2011/2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 and REIPI RD16/0016/006), cofinanced by the European Development Regional Fund “A Way to Achieve Europe” and the operative program Intelligent Growth 2014-2020. This work was also supported by the Galician Innovation Agency (IN607A 2016/22) and the ISCIII-General Subdirection of Assessment and Promotion of the Research (PI15/00860 to G.B. and PI14/00059 to M.P. and A.B.). This study was also supported by the Spanish Ministry of Economy and Competiveness (SAF2016-75638-R), the Xunta de Galicia (Centro Singular de Investigación de Galicia Accreditation 2016-2019, EDG431G/09), and the European Union (European Regional Development Fund-ERDF) to C.G.-B. J.C.V.-U. and A.B. were financially supported by the Miguel Servet Programme ISCIII-FEDER (CP13/00226). M.M. thanks the Spanish Ministry of Science and Innovation for her FPU fellowship. M.M.G. was financially supported by the grant “Clara Roy” from the Spanish Society of Clinical Microbiology and Infectious Diseases. Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI100560, R01AI063517, and R01AI072219 (to R.A.B.) and T32-GM-7250 to Case Western Reserve University, MLW. This study was supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, award number 1I01BX001974, to R.A.B., and by the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development and the Geriatric Research Education and Clinical Center VISN 10 to R.A.B., Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; EDG431G/09, Estados Unidos. National Institute of Allergy and Infectious Diseases; R01AI100560, Estados Unidos. National Institute of Allergy and Infectious Diseases; R01AI063517, Estados Unidos. National Institute of Allergy and Infectious Diseases; R01AI072219, Case Western Reserve University; T32-GM-7250, Cleveland Department of Veterans Affairs; 1I01BX001974, VA Office of Research and Development and the Geriatric Research Education and Clinical Center; VISN 10
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

The Acinetobacter Baumannii OMP33-36 Porin Is a Virulence Factor That Induces Apoptosis and Modulates Autophagy in Human Cells

  • Rumbo, Carlos
  • Tomás, María
  • Fernández-Moreira, Esteban
  • Soares, Nelson C.
  • Carvajal, Micaela
  • Santillana, Elena
  • Beceiro Casas, Alejandro
  • Romero, Antonio
  • Bou, Germán
[Abstract] Acinetobacter baumannii is an extracellular opportunistic human pathogen that is becoming increasingly problematic in hospitals. In the present study, we demonstrate that the A. baumannii Omp 33- to 36-kDa protein (Omp33-36) is a porin that acts as a channel for the passage of water. The protein is found on the cell surface and is released along with other porins in the outer membrane vesicles (OMVs). In immune and connective cell tissue, this protein induced apoptosis by activation of caspases and modulation of autophagy, with the consequent accumulation of p62/SQSTM1 (sequestosome 1) and LC3B-II (confirmed by use of autophagy inhibitors). Blockage of autophagy enables the bacterium to persist intracellularly (inside autophagosomes), with the subsequent development of cytotoxicity. Finally, we used macrophages and a mouse model of systemic infection to confirm that Omp33-36 is a virulence factor in A. baumannii. Overall, the study findings show that Omp33-36 plays an important role in the pathogenesis of A. baumannii infections., This work was supported by Magic Bullet (to G. Bou), a project funded by the European Union's Directorate General for Research and Innovation, through the Seventh Framework Program for Research and Development (grant agreement 278232); the Spanish Network for Research in Infectious Diseases (REIPI-RD12/0015); and Spanish Ministry of Health/FEDER funding (ISCIII-FIS PI12/00552 to G. Bou, FIS PI10/00056 and PI13/02390 to M. Tomás).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Role of Acinetobacter Baumannii UmuD Homologs in Antibiotic Resistance Acquired Through DNA Damage-Induced Mutagenesis

  • Aranda Rodríguez, Jesús
  • López, Mario
  • Leiva, Enoy
  • Magán, Andrés
  • Adler, Ben
  • Bou, Germán
  • Barbé, Jordi
[Abstract] The role of Acinetobacter baumannii ATCC 17978 UmuDC homologs A1S_0636-A1S_0637, A1S_1174-A1S_1173, and A1S_1389 (UmuDAb) in antibiotic resistance acquired through UV-induced mutagenesis was evaluated. Neither the growth rate nor the UV-related survival of any of the three mutants was significantly different from that of the wild-type parental strain. However, all mutants, and especially the umuDAb mutant, were less able to acquire resistance to rifampin and streptomycin through the activities of their error-prone DNA polymerases. Furthermore, in the A. baumannii mutant defective in the umuDAb gene, the spectrum of mutations included a dramatic reduction in the frequency of transition mutations, the mutagenic signature of the DNA polymerase V encoded by umuDC., This study was funded by grants from the Ministerio de Ciencia e Innovación (BFU2011-23478); the European Community, FP 7, ID: 278232 (Magic Bullet); the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III—cofinanced by the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015) and FIS PI12/00552. J.A. is the recipient of a Sara Borrell postdoctoral grant from the Instituto de Salud Carlos III (Madrid, Spain).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Inhibitor-Resistant TEM- And OXA-1-Producing Escherichia Coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content Than Susceptible Clinical Isolates

  • Oteo, Jesús
  • González-López, Juan José
  • Ortega, Adriana
  • Quintero-Zárate, Natalia
  • Bou, Germán
  • Cercenado, Emilia
  • Conejo, María del Carmen
  • Martínez-Martínez, Luis
  • Navarro, Ferrán
  • Oliver, Antonio
  • Bartolomé, Rosa
  • Campos, José
[Abstract] In a previous prospective multicenter study in Spain, we found that OXA-1 and inhibitor-resistant TEM (IRT) β-lactamases constitute the most common plasmid-borne mechanisms of genuine amoxicillin-clavulanate (AMC) resistance in Escherichia coli. In the present study, we investigated the population structure and virulence traits of clinical AMC-resistant E. coli strains expressing OXA-1 or IRT and compared these traits to those in a control group of clinical AMC-susceptible E. coli isolates. All OXA-1-producing (n = 67) and IRT-producing (n = 45) isolates were matched by geographical and temporal origin to the AMC-susceptible control set (n = 56). We performed multilocus sequence typing and phylogenetic group characterization for each isolate and then studied the isolates for the presence of 49 virulence factors (VFs) by PCR and sequencing. The most prevalent clone detected was distinct for each group: group C isolates of sequence type (ST) 88 (C/ST88) were the most common in OXA-1 producers, B2/ST131 isolates were the most common in IRT producers, and B2/ST73 isolates were the most common in AMC-susceptible isolates. The median numbers of isolates per ST were 3.72 in OXA-1 producers, 2.04 in IRT producers, and 1.69 in AMC-susceptible isolates; the proportions of STs represented by one unique isolate in each group were 19.4%, 31.1%, and 48.2%, respectively. The sum of all VFs detected, calculated as a virulence score, was significantly higher in AMC-susceptible isolates than OXA-1 and IRT producers (means, 12.5 versus 8.3 and 8.2, respectively). Our findings suggest that IRT- and OXA-1-producing E. coli isolates resistant to AMC have a different and less diverse population structure than AMC-susceptible clinical E. coli isolates. The AMC-susceptible population also contains more VFs than AMC-resistant isolates., This study was supported by the Plan Nacional de I+D+i 2008-2011 and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015). The study was cofinanced by the European Development Regional Fund (ERDF; A way to achieve Europe) and the Fondo de Investigación Sanitaria (grant PI09/0917).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Monotherapy Versus Combination Therapy for Sepsis Due to Multidrug-Resistant Acinetobacter Baumannii: Analysis of a Multicentre Prospective Cohort

  • López-Cortés, Luis Eduardo
  • Cisneros, José Miguel
  • Fernández-Cuenca, Felipe
  • Bou, Germán
  • Tomás, María
  • Garnacho-Montero, José
  • Pascual, Álvaro
  • Martínez-Martínez, Luis
  • Vila, Jordi
  • Pachón, Jerónimo
  • Rodríguez-Baño, Jesús
Observational study, This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record is available online at: https://doi.org/10.1093/JAC/DKU233., [Abstract] Background: Treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) infection presents a challenge because of the scarcity of available options. Even though combination therapy (CT) is frequently used in clinical practice, data are needed to support its use instead of monotherapy (MT). Methods: A prospective observational study was conducted in 28 Spanish hospitals. Patients with sepsis caused by MDRAB, defined according to strict criteria, and who received active antibiotic treatment (according to in vitro susceptibility testing) for at least 48 h, were included. The main outcome variable was all-cause 30 day mortality after initiation of targeted therapy. Multivariate analysis, including a propensity score (for receiving CT), was performed by Cox regression. Results: One hundred and one patients were included in the analysis; 68 (67.3%) received MT and 33 (32.7%) received CT. Pneumonia was the most common infection (50.5%), 68.6% of cases being associated with mechanical ventilation. Colistin (67.6%) and carbapenems (14.7%) were the most common drugs used in MT; colistin plus tigecycline (27.3%) and carbapenem plus tigecycline (12.1%) were the most frequent combinations. Crude 30 day mortality was 23.5% and 24.2% for the MT and CT groups, respectively (RR = 1.03; 95% CI 0.49-2.16; P = 0.94). Multivariate analysis of 30 day survival showed no trend towards reduced 30 day mortality with CT (HR = 1.35; 95% CI 0.53-3.44; P = 0.53). Subgroup analysis showed similar results. Conclusions: Our data do not support an association of CT with reduced mortality in MDRAB infections. More data for specific types of infection and combinations are needed., Supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III–co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), and ‘Fondo de Investigaciones Sanitarias and Fondos Europeos de Desarrollo Regional-FEDER’ (PI10/00056 and PI11/02046). M. T. was financially supported by the Miguel Servet Programme (C.H.U.A Coruña and ISCIII).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Whole Transcriptome Analysis of Acinetobacter baumannii Assessed by RNA-Sequencing Reveals Different mRNA Expression Profiles in Biofilm Compared to Planktonic Cells

  • Rumbo-Feal, Soraya
  • Gómez, Manuel J.
  • Gayoso Babío, Carmen María
  • Álvarez-Fraga, Laura
  • Cabral, M. P.
  • Aransay, Ana María
  • Rodríguez-Ezpeleta, Naiara
  • Fullaondo, Ane
  • Valle, Jaione
  • Tomás, María
  • Bou, Germán
  • Poza, Margarita
[Abstract] Acinetobacter baumannii has emerged as a dangerous opportunistic pathogen, with many strains able to form biofilms and thus cause persistent infections. The aim of the present study was to use high-throughput sequencing techniques to establish complete transcriptome profiles of planktonic (free-living) and sessile (biofilm) forms of A. baumannii ATCC 17978 and thereby identify differences in their gene expression patterns. Collections of mRNA from planktonic (both exponential and stationary phase cultures) and sessile (biofilm) cells were sequenced. Six mRNA libraries were prepared following the mRNA-Seq protocols from Illumina. Reads were obtained in a HiScanSQ platform and mapped against the complete genome to describe the complete mRNA transcriptomes of planktonic and sessile cells. The results showed that the gene expression pattern of A. baumannii biofilm cells was distinct from that of planktonic cells, including 1621 genes over-expressed in biofilms relative to stationary phase cells and 55 genes expressed only in biofilms. These differences suggested important changes in amino acid and fatty acid metabolism, motility, active transport, DNA-methylation, iron acquisition, transcriptional regulation, and quorum sensing, among other processes. Disruption or deletion of five of these genes caused a significant decrease in biofilm formation ability in the corresponding mutant strains. Among the genes over-expressed in biofilm cells were those in an operon involved in quorum sensing. One of them, encoding an acyl carrier protein, was shown to be involved in biofilm formation as demonstrated by the significant decrease in biofilm formation by the corresponding knockout strain. The present work serves as a basis for future studies examining the complex network systems that regulate bacterial biofilm formation and maintenance., This work was supported by grants from Instituto de Salud Carlos III - Ministerio Economía y Competitividad Unión Europea - Fondo Europeo de Desarrollo Regional (FEDER) PI11/01034 to MP and PI10/00056 to MT, by Ministerio de Economía y Competitividad, Instituto de Salud Carlos III - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015) and Fondo de Investigaciones Sanitarias (PI081638, PI12/00552) to GB and by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) to MJG. CIC bioGUNE support was provided from The Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2010/ 2012) and from the Innovation Technology Department of the Bizkaia County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

OXA-207, a Novel OXA-24 Variant With Reduced Catalytic Efficiency Against Carbapenems in Acinetobacter Pittii From Spain

  • Cayo, Rodrigo
  • Merino Carballeira, María
  • Ruiz del Castillo, Belén
  • Cano, María E.
  • García Calvo-Montes, Jorge
  • Bou, Germán
  • Martínez-Martínez, Luis
Brief report, [Abstract] A carbapenem-resistant Acinetobacter pittii strain carrying an OXA-24-like enzyme was isolated in northern Spain in 2008. Sequence analysis confirmed the presence of the novel bla(OXA-207) gene flanked by the site-specific XerC/XerD-like recombination binding sites and showing a unique Gly222Val substitution compared to OXA-24. Cloning and kinetic analysis showed that OXA-207 presents a reduction in the catalytic efficiency against carbapenems and a noticeable increase for oxacillin., This work was partially supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III - cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and by the Fondo de Investigación Sanitaria (PI080209, PS09/00687, and PI12/00552). We are grateful to the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), which gave a PDEE grant to R.C. (protocol 4149/08-4).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii

  • Beceiro Casas, Alejandro
  • Moreno-Flores, Antonio
  • Fernández, Natalia
  • Vallejo, J. A.
  • Aranda Rodríguez, Jesús
  • Adler, Ben
  • Harper, Marina
  • Boyce, John Dallas
  • Bou, Germán
[Abstract] Two mechanisms of resistance to colistin have been described in Acinetobacter baumannii. One involves complete loss of lipopolysaccharide (LPS), resulting from mutations in lpxA, lpxC, or lpxD, and the second is associated with phosphoethanolamine addition to LPS, mediated through mutations in pmrAB. In order to assess the clinical impacts of both resistance mechanisms, A. baumannii ATCC 19606 and its isogenic derivatives, AL1851 ΔlpxA, AL1852 ΔlpxD, AL1842 ΔlpxC, and ATCC 19606 pmrB, were analyzed for in vitro growth rate, in vitro and in vivo competitive growth, infection of A549 respiratory alveolar epithelial cells, virulence in the Caenorhabditis elegans model, and virulence in a systemic mouse infection model. The in vitro growth rate of the lpx mutants was clearly diminished; furthermore, in vitro and in vivo competitive-growth experiments revealed a reduction in fitness for both mutant types. Infection of A549 cells with ATCC 19606 or the pmrB mutant resulted in greater loss of viability than with lpx mutants. Finally, the lpx mutants were highly attenuated in both the C. elegans and mouse infection models, while the pmrB mutant was attenuated only in the C. elegans model. In summary, while colistin resistance in A. baumannii confers a clear selective advantage in the presence of colistin treatment, it causes a noticeable cost in terms of overall fitness and virulence, with a more striking reduction associated with LPS loss than with phosphoethanolamine addition. Therefore, we hypothesize that colistin resistance mediated by changes in pmrAB will be more likely to arise in clinical settings in patients treated with colistin., This study was funded by grants from the European Community, FP 7 (ID, 278232) (MagicBullet); the Ministerio de Ciencia e Innovación; Instituto de Salud Carlos III, cofinanced by the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015); and Fondo de Investigación Sanitaria (grant PI12/00552).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism

  • Rodríguez-Beltrán, Jerónimo
  • Cabot, Gabriel
  • Valencia, Estela Ynés
  • Costas, Coloma
  • Bou, Germán
  • Oliver, Antonio
  • Blázquez, Jesús
[Abstract] The modulating effect of N-acetylcysteine (NAC) on the activity of different antibiotics has been studied in Pseudomonas aeruginosa. Our results demonstrate that, in contrast to previous reports, only the activity of imipenem is clearly affected by NAC. MIC and checkerboard determinations indicate that the NAC-based modulation of imipenem activity is dependent mainly on OprD. SDS-PAGE of outer membrane proteins (OMPs) after NAC treatments demonstrates that NAC does not modify the expression of OprD, suggesting that NAC competitively inhibits the uptake of imipenem through OprD. Similar effects on imipenem activity were obtained with P. aeruginosa clinical isolates. Our results indicate that imipenem-susceptible P. aeruginosa strains become resistant upon simultaneous treatment with NAC and imipenem. Moreover, the generality of the observed effects of NAC on antibiotic activity was assessed with two additional bacterial species, Escherichia coli and Acinetobacter baumannii. Caution should be taken during treatments, as the activity of imipenem may be modified by physiologically attainable concentrations of NAC, particularly during intravenous and nebulized regimes., This work was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and FIS grant PI13/00063. E.Y.V was funded by a postdoctoral fellowship from CNPq-Brazil (CNPq 236914/2012-0).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

  • Mosqueda, Noraida
  • Gato, Eva
  • Roca, Ignasi
  • Zamora López, María José
  • Ruiz de Alegría-Puig, Carlos
  • Fernández-Cuenca, Felipe
  • Martínez-Martínez, Luis
  • Pachón, Jerónimo
  • Cisneros, José Miguel
  • Rodríguez-Baño, Jesús
  • Pascual, Álvaro
  • Vila, Jordi
  • Bou, Germán
  • Tomás, María
[Abstract] Background: Carbapenem-resistant Acinetobacter baumannii (CRAb) is a major source of nosocomial infections in Spain associated with the production of OXA-58-like or OXA-24/40-like β-lactamase enzymes. We analysed the plasmids carrying the bla(OXA-24/40)-like gene in CRAb isolates obtained a decade apart. Methods: The presence of β-lactamases was screened for by PCR (metallo-β-lactamases, carbapenem-hydrolysing class D β-lactamases, GES and KPC) in 101 CRAb isolates obtained in two multicentre studies (GEIH/REIPI-Ab-2000 and GEIH/REIPI-Ab-2010; n = 493 Acinetobacter spp). We analysed the distribution and characterization of the plasmids carrying the bla(OXA-24/40)-like gene and sequenced two plasmids, AbATCC223p (2000) and AbATCC329p (2010) from A. baumannii ATCC 17978 transformants. Results: Acquisition of the bla(OXA-24/40)-like gene was the main mechanism underlying resistance to carbapenems (48.7% in 2000 compared with 51.6% in 2010). This gene was mainly isolated in ST2 A. baumannii strains in both studies, although some novel STs (ST79 and ST80) appeared in 2010. The gene was located in plasmids (8-12 kbp) associated with the repAci2 or repAci2/repGR12 types. The sequences of AbATCC223p (8840 bp) and AbATCC329p (8842 bp) plasmids were similar, particularly regarding the presence of the genes encoding the AbkA/AbkB proteins associated with the toxin/antitoxin system. Moreover, the abkA/abkB gene sequences (>96% identity) were also located in plasmids harbouring the bla(OXA-58)-like gene. Conclusions: The action of OXA-24/40 and OXA-58 β-lactamase-like enzymes represents the main mechanism underlying resistance to carbapenems in Spain in the last decade. AbkA/AbkB proteins in the toxin/antitoxin system may be involved in the successful dissemination of plasmids carrying the bla(OXA-24/40)-like gene, and probably also the bla(OXA-58)-like gene, thus contributing to the plasmid stability., This work was financially supported by Instituto de Salud Carlos III FEDER, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015) by funding from the European Community (TROCAR contract HEALTH-F3-2008-223031) and by the Spanish Ministry of Health and FEDER funding (FIS PI10/00056-PI13/02390 to M. T. and PI12/00552 to G. B.). M. T. was financially supported by the Miguel Servet Programme (C.H.U.A Coruña and ISCIII).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Draft Genome Sequences of Two Epidemic OXA-48-Producing Klebsiella pneumoniae Clinical Strains Isolated during a Large Outbreak in Spain

  • Poza, Margarita
  • Gato, Eva
  • Álvarez-Fraga, Laura
  • Vallejo, J. A.
  • Rumbo-Feal, Soraya
  • Martínez Guitián, Marta
  • Beceiro Casas, Alejandro
  • Bou, Germán
  • Pérez Gómez, Astrid
[Abstract] We report here the draft genome sequences of Klebsiella pneumoniae strains Kp1803 and Kp3380 isolated during a large outbreak at A Coruña Hospital in Spain. The final genome assemblies for Kp1803 and Kp3380 comprise approximately 6.6 and 6.1 Mb, respectively, and both strains have G+C contents of 57.2%., This work was supported by grants from the Spanish Society of Infectious Diseases and Clinical Microbiology to A.P. and by projects PI11/01034 and P14/00059 to M.P., integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the Instituto de Salud Carlos III (ISCII), General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A Way of Making Europe.” We also thank the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to G.B.), cofinanced by the European Development Regional Fund (EDRF) and by the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain

  • Pérez Gómez, Astrid
  • Merino, María Cecilia
  • Rumbo-Feal, Soraya
  • Álvarez-Fraga, Laura
  • Vallejo, J. A.
  • Beceiro Casas, Alejandro
  • Ohneck, Emily J.
  • Mateos, Jesús
  • Fernández-Puente, Patricia
  • Actis, Luis
  • Poza, Margarita
  • Bou, Germán
[Abstract] Acinetobacter baumannii is a hospital-acquired pathogen that shows an extraordinary capacity to stay in the hospital environment. Adherence of the bacteria to eukaryotic cells or to abiotic surfaces is the first step for establishing an infection. The A. baumannii strain AbH12O-A2 showed an exceptional ability to adhere to A549 epithelial cells. The AbFhaB/FhaC 2-partner secretion (TPS) system involved in adhesion was discovered after the screening of the recently determined A. baumannii AbH12O-A2 strain genome (CP009534.1). The AbFhaB is a large exoprotein which transport to the bacterial surface is mediated by the AbFhaC protein. In the present study, the role of this TPS system in the AbH12O-A2 adherence phenotype was investigated. The functional inactivation of this 2-partner secretion system was addressed by analyzing the outer membrane vesicles (OMV) proteomic profile from the wild-type strain and its derivative mutant AbH12O-A2ΔfhaC demonstrating that AbFhaB is no longer detected in the absence of AbFhaC. Scanning electron microscopy (SEM) and adhesion experiments demonstrated that inactivation of the AbFhaB/FhaC system significantly decreases bacterial attachment to A549 alveolar epithelial cells. Moreover, it has been demonstrated that this 2-partner secretion system is involved in fibronectin-mediated adherence of the A. baumannii AbH12O-A2 isolate. Finally, we report that the AbFhaB/FhaC system is involved in virulence when tested using invertebrate and vertebrate hosts. These data suggest the potential role that this AbFhaB/FhaC secretion system could play in the pathobiology of A. baumannii., This work has been funded by Projects PI12/00552 and PI15/00860 to GB, PI11/01034 to MP, CP13/00226 to AB, and P14/000059 to MP and AB, all integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII - General Subdirection of Assessment and Promotion of the Research – European Regional Development Fund (FEDER) “A way of making Europe.” Miami University Research Funds from the department of Microbiology supported this work. We also want to thank the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to GB), co-financed by the European Development Regional Fund (EDRF) “A Way to Achieve Europe, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad as well as Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). A.P. was financially supported by the Galician Plan for Research, Innovation and Growth (I2C Plan 2012–2016). J. A. Vallejo was financially supported by the Sara Borrell Program (ISCIII, Spain CD13/00373). S. Rumbo-Feal was financially supported by the Agustí Pumarola Grant (Societat Catalana de Malalties Infeccioses i Microbiologia Clínica, SCMIMC) and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Finally, we thank Chua Kim Lee (University of Singapore) for providing pMo130-TelR.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Simple and fast detection of resistance to antibiotic inhibitors of protein synthesis in Gram-negative pathogens through evaluation of mitomycin C-Induced cell elongation

  • Otero, Fátima
  • Gosálvez, Jaime
  • Bou, Germán
  • Fernández, José Luis
[Abstract] Increasing the resistance of Gram-negative pathogens to antibiotics that inhibit protein synthesis is of great concern. In life-threatening situations, an early detection of antibiotic resistance may improve patient outcome. A rapid assay for the identification of antibiotic resistance to gentamicin, tobramycin, and tigecycline has been designed and tested in clinical strains of Acinetobacter baumannii, Pseudomonas aeruginosa, and the Enterobacteriaceae Escherichia coli and Klebsiella pneumoniae. Exponentially growing cultures were incubated with 0.5 mg/L mitomycin C (MMC) for 2 hr (10 mg/L for A. baumannii), which induced significant cell enlargement as visualized under the microscope. Addition of the appropriate antibiotic dose 15 min before the addition of MMC prevented elongation when the strain was susceptible to the antibiotic, thereby inhibiting protein synthesis. Cell enlargement was not precluded in the antibiotic resistant strains, where protein synthesis had not been successfully inhibited. In comparison with the standard dilution-based antibiogram, the sensitivity of the assay was 100% and the specificity ranged between 96.0% and 100%. Results were obtained after 2 hr and 45 min from exponentially growing cultures. The procedure is easy, reliable, and demonstrates the suitability of the evaluation of simple morphological changes, which are protein synthesis dependent, for the rapid detection of antibiotic resistance., This work was supported by the Fondo de Investigaciones Sanitarias (PI14/01346) and REIPI, Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III, RD12/0015/0014). This work was also funded by IMI 6th call COMBACTE New Drugs 4 Bad Bugs (ND4BB).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis

  • Oviaño, Marina
  • Rodríguez-Martínez, José Manuel
  • Pascual, Álvaro
  • Bou, Germán
[Abstract] Objectives: Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by measuring acetyltransferase activity against fluoroquinolones by MALDI-TOF MS analysis. Methods: The presence of the AAC(6')-Ib-cr enzyme was determined by MS by measuring the acetyltransferase activity of a collection of 81 isogenic Escherichia coli control strains [10 carrying the AAC(6')-Ib-cr enzyme during exposure to ciprofloxacin, norfloxacin and levofloxacin] and further analysis of 36 clinical isolates [25 carrying the AAC(6')-Ib-cr enzyme in addition to different combinations of quinolone resistance mechanisms]. The effect of acetylation yields an increase of 43 Da in the mass of ciprofloxacin and norfloxacin, but not of levofloxacin, that can be observed by visual inspection of the mass peaks in the spectra. Results: Based on the characteristic peak pattern for the acetylated and non-acetylated forms of ciprofloxacin and norfloxacin, a clear differentiation between AAC(6')-Ib-cr-producing isolates and non-AAC(6')-Ib-cr-producing isolates was detected after an incubation time of 30 min, both in the isogenic control strains and in the clinical isolates. Levofloxacin was found intact. A 100% agreement was found between the MALDI-TOF-MS-based assay and the results of the molecular characterization of the tested isolates. Conclusions: MALDI-TOF MS is an outstanding method for detection of the AAC(6')-Ib-cr enzyme in clinical samples. The method is easy to perform and not time consuming, as analytical results can be obtained within minutes. For the first time, MALDI-TOF MS has been used to detect resistance promoted by enzymatic modification of antibiotics aside from β-lactamases, expanding the capacity of analysis into new families of antibiotics., This work was supported by the Fondo de Investigación Sanitaria (grant numbers PI12/00552 and PI15/00860 to G. B. and PI11-00934 to J. M. R.-M.) integrated in the Plan Nacional de I + D and funded by the Instituto de Salud Carlos III (ISCIII). We also thank the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to G. B.), Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad and co-financed by European Development Regional Fund ‘A Way to Achieve Europe’ ERDF. M. O. is financially supported by the Río Hortega Programme of the ISCIII (CM15/00155).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Diagnosis and Antimicrobial Treatment of Invasive Infections Due to Multidrug-Resistant Enterobacteriaceae: Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology

  • Rodríguez-Baño, Jesús
  • Cisneros, José Miguel
  • Cobos-Trigueros, Nazaret
  • Fresco, Gema
  • Navarro-San Francisco, Carolina
  • Gudiol, Carlota
  • Horcajada, Juan Pablo
  • López-Cerero, Lorena
  • Serrano Martínez, José Antonio
  • Molina Gil-Bermejo, José
  • Montero, Milagro
  • Paño-Pardo, José Ramón
  • Pascual, Álvaro
  • Peña, Carmen
  • Pintado, Vicente
  • Retamar-Gentil, Pilar
  • Tomás, María
  • Borges-Sá, Márcio M.
  • Garnacho-Montero, José
  • Bou, Germán
Practice guideline, [Abstract] The spread of multidrug-resistant Enterobacteriaceae related to the production of extended-spectrum β-lactamases and carbapenemases is a serious public health problem worldwide. Microbiological diagnosis and therapy of these infections are challenging and controversial. Clinically relevant questions were selected and the literature was reviewed for each of them. The information from the selected articles was extracted and recommendations were provided and graded according to the strength of the recommendations and quality of the evidence. The document was opened to comments from the members from the Spanish Society of Infectious Diseases and Clinical Microbiology, which were considered for inclusion in the final version. Evidence-based recommendations are provided for the use of microbiological techniques for the detection of extended-spectrum β-lactamases and carbapenemases in Enterobacteriaceae, and for antibiotic therapy for invasive/severe infections caused by these organisms. The absence of randomised controlled trials is noteworthy; thus, recommendations are mainly based on observational studies (that have important methodological limitations), pharmacokinetic and pharmacodynamics models, and data from animal studies. Additionally, areas for future research were identified., [Resumen] La diseminación de Enterobacteriaceae multirresistentes en relación con la producción de β-lactamasas de espectro extendido y carbapenemasas es un importante problema de salud pública en todo el mundo. Tanto el diagnóstico microbiológico como el tratamiento de estas infecciones son complicados y controvertidos. Los autores seleccionaron preguntas clínicamente relevantes, realizándose una revisión de la literatura para cada una de ellas; se obtuvo información de los artículos seleccionados y se realizaron recomendaciones que se clasificaron de acuerdo con la fuerza de la recomendación y la calidad de la evidencia. El documento estuvo abierto para los comentarios de los socios de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, los cuales se consideraronpara su inclusión en la versión final. Se proporcionan recomendaciones basadas en la evidencia para el uso de técnicas microbiológicas cara a la detección de β-lactamasas de espectro extendido y carbapenemasas en Enterobacteriaceae, y para el tratamiento antimicrobiano de las infecciones graves o invasivas causadas por estos microorganismos. Es llamativa la ausencia de ensayos aleatorizados, por lo que las recomendaciones se basan principalmente en estudios observacionales que tienen importantes limitaciones metodológicas, modelos farmacocinéticos y farmacodinámicos, y datos de estudios en animales. Además, se identificaron áreas prioritarias para la investigación futura., Supported by the Spanish Society of Clinical Microbiology and Infectious Diseases, and Ministerio de Economía y Competitividad, Instituto de Salud Carlos III – co-financed by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Rapid assessment of resistance to antibiotic inhibitors of protein synthesis in the gram-positive pathogens, enterococcus faecalis and streptococcus pneumoniae, based on evaluation of the lytic response

  • Otero, Fátima
  • Tamayo, María
  • Santiso, Rebeca
  • Gosálvez, Jaime
  • Bou, Germán
  • Fernández, José Luis
[Abstract] A novel assay for rapid determination of resistance to antibiotic inhibitors of protein synthesis was developed for the gram-positive pathogens, Enterococcus faecalis and Streptococcus pneumoniae. To this purpose, a lytic response was obtained by a brief incubation with lysozyme or a mixture of lysozyme, Triton X-100, and EDTA for E. faecalis (n = 82) and S. pneumoniae (n = 51), respectively. Lysis was quantified by visualizing the released nucleoids. Antibiotic-susceptible bacteria treated with Clinical and Laboratory Standards Institute (CLSI) breakpoint doses of erythromycin, azithromycin, or doxycycline that inhibited protein synthesis demonstrated a large reduction of lysed cells with respect to the control, that is, without antibiotics. However, cell lysis prevention was much lower in nonsusceptible strains, with unsuccessful inhibition of protein synthesis. ROC analysis showed that a reduction value of ≥35.6% and ≥40.4% discriminates susceptible and nonsusceptible strains for erythromycin and for doxycycline, respectively, in E. faecalis, whereas ≥20.0% is adequate for both macrolides and doxycycline in S. pneumoniae. Resistant stains were identified in 90-120 min with sensitivity and specificity between 91.7% and 100%. This is a proof of concept that evaluation of the lytic response may be a rapid and efficient test for determination of resistance to antibiotic inhibitors of protein synthesis., his work was supported by the Fondo de Investigaciones Sanitarias (PI14/01346) and REIPI, Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III, RD12/0015/0014). This work was also funded by IMI 6th call COMBACTE New Drugs 4 Bad Bugs (ND4BB).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

In vitro and in vivo activities of -lactams in combination with the novel -lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-lactamase-producing klebsiella pneumoniae

  • Moya, Bartolomé
  • Barceló, Isabel M.
  • Cabot, Gabriel
  • Torrens Ribot, Gabriel
  • Palwe, Snehal
  • Joshi, Prashant
  • Umarkar, Kushal
  • Takalkar, Swapna
  • Periasamy, Hariharan
  • Bhagwat, Sachin
  • Patel, Mahesh
  • Bou, Germán
  • Oliver, Antonio
[Abstract] Zidebactam and WCK 5153 are novel bicyclo-acyl hydrazide (BCH) agents that have previously been shown to act as β-lactam enhancer (BLE) antibiotics in Pseudomonas aeruginosa and Acinetobacter baumannii The objectives of this work were to identify the molecular targets of these BCHs in Klebsiella pneumoniae and to investigate their potential BLE activity for cefepime and aztreonam against metallo-β-lactamase (MBL)-producing strains in vitro and in vivo Penicillin binding protein (PBP) binding profiles were determined by Bocillin FL assay, and 50% inhibitory concentrations (IC50s) were determined using ImageQuant TL software. MICs and kill kinetics for zidebactam, WCK 5153, and cefepime or aztreonam, alone and in combination, were determined against clinical K. pneumoniae isolates producing MBLs VIM-1 or NDM-1 (plus ESBLs and class C β-lactamases) to assess the in vitro enhancer effect of BCH compounds in conjunction with β-lactams. Additionally, murine systemic and thigh infection studies were conducted to evaluate BLE effects in vivo Zidebactam and WCK 5153 showed specific, high PBP2 affinity in K. pneumoniae The MICs of BLEs were >64 μg/ml for all MBL-producing strains. Time-kill studies showed that a combination of these BLEs with either cefepime or aztreonam provided 1 to >3 log10 kill against MBL-producing K. pneumoniae strains. Furthermore, the bactericidal synergy observed for these BLE-β-lactam combinations translated well into in vivo efficacy even in the absence of MBL inhibition by BLEs, a characteristic feature of the β-lactam enhancer mechanism of action. Zidebactam and WCK 5153 are potent PBP2 inhibitors and display in vitro and in vivo BLE effects against multidrug-resistant (MDR) K. pneumoniae clinical isolates producing MBLs., This work was supported by Wockhardt Bio AG, Switzerland, and by the Ministerio de Economía y Competitividad of Spain, Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund A Way to Achieve Europe ERDF through the Spanish Network for Research in Infectious Diseases (grants number RD12/0015 and RD16/0016).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS)

  • Oviaño, Marina
  • Sparbier, Katrin
  • Barba, María José
  • Kostrzewa, Markus
  • Bou, Germán
[Abstract] Detection of carbapenemase-producing bacteria directly from blood cultures is a major challenge, as patients with bacteraemia are critically ill. Early detection can be helpful for selection of the most appropriate antibiotic therapy as well as adequate control of outbreaks. In the current study, a novel matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF)-based method was developed for the rapid, automated detection of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii directly from blood cultures. Carbapenemase activity was determined in 30 min by measuring hydrolysis of imipenem (0.31 mg/mL) in blood cultures spiked with a series of 119 previously characterised isolates, 81 of which carried a carbapenemase enzyme (10 blaKPC, 10 blaVIM, 10 blaNDM, 10 blaIMP, 26 blaOXA-48-type, 9 blaOXA-23, 1 blaOXA-237, 3 blaOXA-24 and 2 blaOXA-58). Twenty blood cultures obtained from bacteraemic patients carrying blaOXA-48-producing isolates were also analysed using the same protocol. Analysis was performed using MALDI-TOF Biotyper® Compass software, which automatically provides a result of sensitivity or resistance, calculated as the logRQ or ratio of hydrolysis of the antibiotic. This assay is simple to perform, inexpensive, time saving, universal for Gram-negative bacilli, and highly reliable (overall sensitivity and specificity of 98% and 100%, respectively). Moreover, the protocol could be established as a standardised method in clinical laboratories as it does not require specialised training in mass spectrometry., This work was supported by a grant from the Fondo de Investigación Sanitaria [Grant No. PI12/00512 to GB] and Plan Nacional de I+D and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases [REIPI RD12/0015/0014] co-financed by the European Development Regional Fund ‘A Way to achieve Europe’ ERDF. MO is financially supported by the Río Hortega Programme of the ISCIII [CM15/00155].
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Quantitative Proteomic Analysis of Host—Pathogen Interactions: A Study of Acinetobacter baumannii Responses to Host Airways

  • Méndez Arredondo, José Antonio
  • Mateos, Jesús
  • Beceiro Casas, Alejandro
  • López Díaz, María
  • Tomás, María
  • Poza, Margarita
  • Bou, Germán
Additional files: 1. Workflow of the proteomic experiment -- 2. Histopathology shows signs of consolidated pneumonia in infected animals -- 3. Prediction of exoproteins -- 4. RT-PCR analysis of different genes. Primers and Univesal ProbeLibrary (UPL, Roche) probes used in this study -- 5. Protein identification data., [Abstract] Background: Acinetobacter baumannii is a major health problem. The most common infection caused by A. baumannii is hospital acquired pneumonia, and the associated mortality rate is approximately 50 %. Neither in vivo nor ex vivo expression profiling has been performed at the proteomic or transcriptomic level for pneumonia caused by A. baumannii. In this study, we characterized the proteome of A. baumannii under conditions that simulate those found in the airways, to gain some insight into how A. baumannii adapts to the host and to improve knowledge about the pathogenesis and virulence of this bacterium. A clinical strain of A. baumannii was grown under different conditions: in the presence of bronchoalveolar lavage fluid from infected rats, of RAW 264.7 cells to simulate conditions in the respiratory tract and in control conditions. We used iTRAQ labelling and LC-MALDI-TOF/TOF to investigate how A. baumannii responds on exposure to macrophages/BALF. Results: 179 proteins showed differential expression. In both models, proteins involved in the following processes were over-expressed: (i) pathogenesis and virulence (OmpA, YjjK); (ii) cell wall/membrane/envelope biogenesis (MurC); (iii) energy production and conversion (acetyl-CoA hydrolase); and (iv) translation (50S ribosomal protein L9). Proteins involved in the following were under-expressed: (i) lipid metabolism (short-chain dehydrogenase); (ii) amino acid metabolism and transport (aspartate aminotransferase); (iii) unknown function (DNA-binding protein); and (iv) inorganic ion transport and metabolism (hydroperoxidase). Conclusions: We observed alterations in cell wall synthesis and identified 2 upregulated virulence-associated proteins with >15 peptides/protein in both ex vivo models (OmpA and YjjK), suggesting that these proteins are fundamental for pathogenesis and virulence in the airways. This study is the first comprehensive overview of the ex vivo proteome of A. baumannii and is an important step towards identification of diagnostic biomarkers, novel drug targets and potential vaccine candidates in the fight against pneumonia caused by A. baumannii., This study was funded by grants from the European Community, FP7, ID: 278232 (MagicBullet), and by the Plan Nacional de I+D+I 2008-2011 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014), cofinanced by the European Development Regional Fund (EDRF) “A Way to Achieve Europe.” M. T. and A.B. were financially supported by the Miguel Servet Programme ISCIII-FEDER (CP09/00033 and CP13/00226, respectively). This work was supported by the National Plans for Scientific Research, Development and Technological Innovation 2008-2011 and 2013-2016 and funded by the ISCIII- General Subdirection of Assesment and Promotion of the Research – European Regional Development Fund (ERDF) “A way of making Europe”: PI10/00056 and PI13/02390 to M. T., PI11/01034 to M.P., PI12/00552 to G.B. and PI14/00059 to M.P. and A.B.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Complete Genome Sequence of the Multiresistant Acinetobacter baumannii Strain AbH12O-A2, Isolated during a Large Outbreak in Spain

  • Merino Carballeira, María
  • Álvarez-Fraga, Laura
  • Gómez, Manuel J.
  • Aransay, Ana María
  • Lavín, José Luis
  • Chaves Sánchez, Fernando
  • Bou, Germán
  • Poza, Margarita
[Abstract] We report the complete genome sequence of Acinetobacter baumannii strain AbH12O-A2, isolated during a large outbreak in Spain. The genome has 3,875,775 bp and 3,526 coding sequences, with 39.4% G+C content. The availability of this genome will facilitate the study of the pathogenicity of the Acinetobacter species., This work was supported by grants from the Instituto de Salud Carlos III—Ministerio Economía y Competitividad Unión Europea—Fondo Europeo de Desarrollo Regional (FEDER) PI11/01034, awarded to M.P., and from the Spanish Network for the Research in Infectious Diseases (REIPI) RD12/0015 awarded to G.B.), the Departamento de Desarrollo Económico y Competitividad del Gobierno Vasco (GV)—Etortek Research Programs 2011–2013 (EI11-300 and IE13-370), and the Diputacion Foral de Bizkaia (DFB)—Departamento de Promoción Económica awarded to A.M.A. and J.L.L., Gobierno Vasco; EI11-300, Gobierno Vasco; IE13-370
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Pneumonia infection in mice reveals the involvement of the feoA gene in the pathogenesis of Acinetobacter baumannii

  • Poza, Margarita
  • Álvarez-Fraga, Laura
  • Vázquez-Ucha, Juan Carlos
  • Martínez Guitián, Marta
  • Vallejo, J. A.
  • Bou, Germán
  • Beceiro Casas, Alejandro
[Abstract] Acinetobacter baumannii has emerged in the last decade as an important nosocomial pathogen. To identify genes involved in the course of a pneumonia infection, gene expression profiles were obtained from A. baumannii ATCC 17978 grown in mouse infected lungs and in culture medium. Gene expression analysis allowed us to determine a gene, the A1S_0242 gene (feoA), over-expressed during the pneumonia infection. In the present work, we evaluate the role of this gene, involved in iron uptake. The inactivation of the A1S_0242 gene resulted in an increase susceptibility to oxidative stress and a decrease in biofilm formation, in adherence to A549 cells and in fitness. In addition, infection of G. mellonella and pneumonia in mice showed that the virulence of the Δ0242 mutant was significantly attenuated. Data presented in this work indicated that the A1S_0242 gene from A. baumannii ATCC 17978 strain plays a role in fitness, adhesion, biofilm formation, growth, and, definitively, in virulence. Taken together, these observations show the implication of the feoA gene plays in the pathogenesis of A. baumannii and highlight its value as a potential therapeutic target., This work has been funded by Projects PI15/00860 to GB, CP13/00226 to AB, PI11/01034 to MP and P14/00059 and PI17/01482 to MP and AB, all integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII – General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe”. The study was also funded by the project IN607A 2016/22 (Consellería de Cultura, Educación e Ordenación Universitaria) to G.B. Also supported by Planes Nacionales de I+D+i 2008–2011 / 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 and REIPI RD16/0016/006) co-financed by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth 2014–2020. J. A. Vallejo was financially supported by the Sara Borrell Programme (ISCIII, Spain CD13/00373), J.C. Vázquez-Ucha was financially supported by the Miguel Servet Programme (ISCIII, Spain CP13/00226) and M. Martínez-Guitián was financially supported by the grant Clara Roy (Spanish Society of Clinical Microbiology and Infectious Diseases). We thank M. I. Voskuil (Dept. of Immunology and Microbiology, University of Colorado Medical School, CO, USA) for providing pMo130., Xunta de Galicia. Consellería de Cultura, Educación e Ordenación Universitaria; IN607A 2016/22
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality

  • Garnacho-Montero, José
  • Gutiérrez-Pizarraya, A.
  • Escoresca-Ortega, Ana
  • Fernández-Delgado, Esperanza
  • López-Sánchez, José María
[Introduction] In patients with severe sepsis and septic shock as cause of Intensive Care Unit (ICU) admission, we analyze the impact on mortality of adequate antimicrobial therapy initiated before ICU admission., [Methods] We conducted a prospective observational study enrolling patients admitted to the ICU with severe sepsis or septic shock from January 2008 to September 2013. The primary end-point was in-hospital mortality. We considered two groups for comparisons: patients who received adequate antibiotic treatment before or after the admission to the ICU., [Results] A total of 926 septic patients were admitted to ICU, and 638 (68.8%) had available microbiological isolation: 444 (69.6%) received adequate empirical antimicrobial treatment prior to ICU and 194 (30.4%) after admission. Global hospital mortality in patients that received treatment before ICU admission, between 0-6h ICU, 6–12h ICU, 12–24h ICU and after 24 hours since ICU admission were 31.3, 53.2, 57.1, 50 and 50.8% (p<0.001). The multivariate analysis showed that urinary focus (odds ratio (OR) 0.20; 0.09–0.42; p<0.001) and adequate treatment prior to ICU admission (OR 0.37; 0.24–0.56; p<0.001) were protective factors whereas APACHE II score (OR 1.10; 1.07–1.14; p<0.001), septic shock (OR 2.47; 1.57–3.87; p<0.001), respiratory source (OR 1.91; 1.12–3.21; p=0.016), cirrhosis (OR 3.74; 1.60–8.76; p=0.002) and malignancy (OR 1.65; 1.02–2.70; p=0.042) were variables independently associated with in-hospital mortality. Adequate treatment prior to ICU was a protective factor for mortality in patients with severe sepsis (n=236) or in septic shock (n=402)., [Conclusions] The administration of adequate antimicrobial therapy before ICU admission is decisive for the survival of patients with severe sepsis and septic shock. Our efforts should be directed to assure the correct administration antibiotics before ICU admission in patients with sepsis., This study was supported by Ministerio de Economía y Competitividad, Instituto de Salud Carlos III co-financed by the European Development Regional Fund “A Way to Achieve Europe”, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

  • Fernández-Ruiz, Mario
  • Puig-Asensio, Mireia
  • Guinea, Jesús
  • Almirante, Benito
  • Padilla, Belén
  • Almela, Manuel
  • Díaz-Martín, Ana
  • Rodríguez-Baño, Jesús
  • Cuenca-Estrella, Manuel
  • Aguado, José María
  • GEIH-GEMICOMED (SEIMC)
  • Ruiz Pérez de Pipaón, Maite
  • Garnacho, José
  • Red Española de Investigación en Patología Infecciosa
[Objective] To assess the current clinical features and determinants of outcome of Candida tropicalis bloodstream infection (BSI)., [Methods] A population-based surveillance on Candida BSI was conducted from May 2010 to April 2011 in 29 Spanish hospitals. Antifungal susceptibility testing (EUCAST methodology) was centrally performed. The characteristics and outcome of C. tropicalis BSI episodes were compared with those due to other species., [Results] Fifty-nine out of 752 episodes (7.8%) were due to C. tropicalis (annual incidence: 0.62 cases per 100,000 population). Resistance to fluconazole and voriconazole was found in 23.2% and 26.8% of isolates. Breakthrough BSI occurred in 10.5% of episodes. Risk factors for C. tropicalis BSI were age (odds ratio [OR]: 1.01; P-value = 0.05), underlying leukaemia (OR: 4.77; P-value = 0.001) and chronic lung disease (OR: 2.62; P-value = 0.002). There were no differences in clinical failure (persistent BSI for ≥72 h after initiation of therapy and/or 30-day all-cause mortality) between C. tropicalis (39.6%) and non-C. tropicalis groups (45.6%). The appropriateness of antifungal therapy or the fluconazole MIC values had no significant impact on outcome, whereas early central venous catheter removal exerted a protective effect., [Conclusions] C. tropicalis BSI was associated with advanced age, haematological malignancy and respiratory comorbidity. We found no correlation between the unexpectedly high resistance rate to azoles observed and outcome., This work was supported by non-restrictive research grants from Gilead, MSD, Astellas, and Pfizer. This study was cofounded by Fundación SEIMC-GESIDA, by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (co-financed by the European Development Regional Fund [ERDF] “A way to achieve Europe”), and by the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study

  • Rodríguez-Martínez, José-Manuel
  • Machuca, Jesús
  • Calvo, Jorge
  • Díaz-de-Alba, Paula
  • Rodríguez-Mirones, Cristina
  • Gimeno, Concha
  • Martínez-Martínez, Luis
  • Pascual, Álvaro
[Objectives] The objective of this study was to evaluate the proficiency of Spanish laboratories with respect to accurate susceptibility testing and the detection and interpretation of quinolone resistance phenotypes in Enterobacteriaceae., [Methods] Thirteen strains of Enterobacteriaceae were sent to 62 participating centres throughout Spain; strains harboured GyrA/ParC modifications, reduced permeability and/or plasmid-mediated quinolone resistance genes. The centres were requested to evaluate nalidixic acid and five quinolones, provide raw/interpreted clinical categories and to detect/infer resistance mechanisms. Consensus results from reference centres were used to assign minor, major and very major errors (mEs, MEs and VMEs, respectively)., [Results] Susceptibility testing in the participating centres was frequently performed using the MicroScan WalkAway, Vitek 2 and Wider systems (48%, 30% and 8%, respectively). CLSI/EUCAST breakpoints were used in 71%/29% of the determinations. The percentage of VMEs for all quinolones was well below 2%. Only ofloxacin and moxifloxacin showed higher values for raw VMEs (6.6%), which decreased to 0% and 2.9%, respectively, in the interpreted VMEs. These errors were particularly associated with the CC-03 strain [qnrS2 + aac(6′)-Ib-cr]. For MEs, percentages were always <10%, except in the case of ofloxacin and nalidixic acid. There was a significantly higher percentage of all types of errors for strains whose MICs were at the border of clinical breakpoints., [Conclusion] The use of different breakpoints and methods, the complexity of mutation-driven and transferable resistance mechanisms and the absence of specific tests for detecting low-level resistance lead to high variability and represent a challenge to accuracy in susceptibility testing, particularly in strains with MICs on the border of clinical breakpoints., This work was supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (projects PI11-00934 and PI11/01117) and the Consejería de Innovación Ciencia y Empresa, Junta de Andalucía (P11-CTS-7730), Spain, by the Plan Nacional de I+D+i 2008-2011 and the Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology, Diagnóstico y tratamiento de las infecciones invasivas causadas por Enterobacteriaceae multirresistentes. Guía de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

  • Rodríguez-Baño, Jesús
  • Cisneros, José Miguel
  • Cobos-Trigueros, Nazaret
  • Fresco, Gema
  • Navarro-San Francisco, Carolina
  • Gudiol, Carlota
  • Horcajada, Juan Pablo
  • López-Cerero, Lorena
  • Martínez, José Antonio
  • Molina, José
  • Montero, Milagro
  • Paño, José Ramón
  • Pascual, Álvaro
  • Peña, Carmen
  • Pintado, Vicente
  • Retamar Gentil, Pilar
  • Tomás, María
  • Borges-Sa, Marcio
  • Garnacho-Montero, José
  • Bou, Germán
[EN] The spread of multidrug-resistant Enterobacteriaceae related to the production of extended-spectrum β-lactamases and carbapenemases is a serious public health problem worldwide. Microbiological diagnosis and therapy of these infections are challenging and controversial., Clinically relevant questions were selected and the literature was reviewed for each of them. The information from the selected articles was extracted and recommendations were provided and graded according to the strength of the recommendations and quality of the evidence. The document was opened to comments from the members from the Spanish Society of Infectious Diseases and Clinical Microbiology, which were considered for inclusion in the final version., Evidence-based recommendations are provided for the use of microbiological techniques for the detection of extended-spectrum β-lactamases and carbapenemases in Enterobacteriaceae, and for antibiotic therapy for invasive/severe infections caused by these organisms. The absence of randomised controlled trials is noteworthy; thus, recommendations are mainly based on observational studies (that have important methodological limitations), pharmacokinetic and pharmacodynamics models, and data from animal studies. Additionally, areas for future research were identified., [ES] La diseminación de Enterobacteriaceae multirresistentes en relación con la producción de β-lactamasas de espectro extendido y carbapenemasas es un importante problema de salud pública en todo el mundo. Tanto el diagnóstico microbiológico como el tratamiento de estas infecciones son complicados y controvertidos., Los autores seleccionaron preguntas clínicamente relevantes, realizándose una revisión de la literatura para cada una de ellas; se obtuvo información de los artículos seleccionados y se realizaron recomendaciones que se clasificaron de acuerdo con la fuerza de la recomendación y la calidad de la evidencia. El documento estuvo abierto para los comentarios de los socios de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, los cuales se consideraronpara su inclusión en la versión final., Se proporcionan recomendaciones basadas en la evidencia para el uso de técnicas microbiológicas cara a la detección de β-lactamasas de espectro extendido y carbapenemasas en Enterobacteriaceae, y para el tratamiento antimicrobiano de las infecciones graves o invasivas causadas por estos microorganismos. Es llamativa la ausencia de ensayos aleatorizados, por lo que las recomendaciones se basan principalmente en estudios observacionales que tienen importantes limitaciones metodológicas, modelos farmacocinéticos y farmacodinámicos, y datos de estudios en animales. Además, se identificaron áreas prioritarias para la investigación futura., Supported by the Spanish Society of Clinical Microbiology and Infectious Diseases, and Ministerio de Economía y Competitividad, Instituto de Salud Carlos III – co-financed by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Meropenem heteroresistance in clinical isolates of OXA-48–producing Klebsiella pneumoniae

  • López-Camacho, E.
  • Paño-Pardo, J.R.
  • Sotillo, A.
  • Elías-López, C.
  • Martínez-Martínez, L.
  • Gómez-Gil, R.
  • Mingorance, J.
OXA-48–producing Klebsiella pneumoniae isolates often show growth of colonies within inhibition zones in carbapenem diffusion assays. The nature of these colonies was investigated in a series of clinical isolates of OXA-48–producing K. pneumoniae obtained in the context of a hospital outbreak, and they were found to be persistent colonies that reproduced again the same phenotype when they were collected and tested in diffusion assays again. The frequency of mutations conferring resistance to meropenem (8 µg/mL) was determined for the same isolates. The average mutation frequency was 5.47·10-6 (range: 2.59·10-8–5.87·10-5), and the analysis of several resistant mutants showed that all of them had mutations in the ompK36 porin gene. Heteroresistance was investigated using population analysis profiling. The profiles were compatible with mutation frequency assays, and all the colonies analyzed were resistant mutants. In OXA-48–producing K. pneumoniae, the growth of persisters seems to be specific of diffusion assays.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model

  • Basas Satorras, Jana|||0000-0002-7934-1734
  • Palau Gauthier, Marta|||0000-0002-4567-9868
  • Gomis, Xavier
  • Almirante Gragera, Benito|||0000-0002-1189-2361
  • Gavaldà, Joan|||0000-0002-9829-3141
Objective: The aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs. Second, we sought to compare the activity of LAmB versus anidulafungin for the treatment of experimental catheter-related C. albicans and C. glabrata infections with the antifungal lock technique in a rabbit model. Methods: Two C. albicans and two C. glabrata clinical strains were used. The minimum biofilm eradication concentration for 90% eradication (MBEC ) values were determined after 48h of treatment with LAmB and anidulafungin. Confocal microscopy was used to visualize the morphology and viability of yeasts growing in biofilms. Central venous catheters were inserted into New Zealand rabbits, which were inoculated of each strain of C. albicans and C. glabrata. Then, catheters were treated for 48h with saline or with antifungal lock technique using either LAmB (5mg/mL) or anidulafungin (3.33mg/mL). Results: In vitro: anidulafungin showed greater activity than LAmB against C. albicans and C. glabrata strains. For C. albicans: MBEC of anidulafungin versus LAmB: CA176, 0.03 vs. 128 mg/L; CA180, 0.5 vs. 64 mg/L. For C. glabrata: MBEC of anidulafungin versus LAmB: CG171, 0.5 vs. 64 mg/L; CG334, 2 vs. 32 mg/L. In vivo: for C. albicans species, LAmB and anidulafungin achieved significant reductions relative to growth control of log cfu recovered from the catheter tips (CA176: 3.6±0.3 log CFU, p0.0001; CA180: 3.8±0.1 log CFU, p0.01). For C. glabrata, anidulafungin lock therapy achieved significant reductions relative to the other treatments (CG171: 4.8 log CFU, p0.0001; CG334: 5.1 log CFU, p0.0001) Conclusions: For the C. albicans strains, both LAmB and anidulafungin may be promising antifungal lock technique for long-term catheter-related infections; however, anidulafungin showed significantly higher activity than LAmB against the C. glabrata strains.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibiotic treatment versus no treatment for asymptomatic bacteriuria in kidney transplant recipients, A multicenter randomized trial

  • Sabé, Núria|||0000-0003-1697-4347
  • Oriol, Isabel|||0000-0001-5542-7878
  • Melilli, Edoardo|||0000-0001-6965-3745
  • Manonelles, Anna|||0000-0003-2456-388X
  • Bestard, Oriol|||0000-0001-9468-7920
  • Polo, Carolina
  • Los-Arcos, Ibai|||0000-0001-8835-2702
  • Perelló, Manel|||0000-0003-1859-5279
  • Garcia, Dolors
  • Riera, Lluís
  • Tebé, Cristian|||0000-0003-2320-1385
  • Len, Oscar|||0000-0002-1819-3141
  • Moreso, Francesc.|||0000-0002-7267-3963
  • Cruzado, Josep María
  • Carratalà, Jordi|||0000-0003-3209-2563
Background: Whether antibiotic treatment of asymptomatic bacteriuria (AB) can prevent acute graft pyelonephritis (AGP) in kidney transplant (KT) recipients has not been elucidated. Methods: In this multicenter, open-label, nonblinded, prospective, noninferiority, randomized controlled trial, we compared antibiotic treatment with no treatment for AB in KT recipients in the first year after transplantation when urinary catheters had been removed. The primary endpoint was the occurrence of AGP. Secondary endpoints included bacteremic AGP, cystitis, susceptibility of urine isolates, graft rejection, graft function, graft loss, opportunistic infections, need for hospitalization, and mortality. Results: We enrolled 205 KT recipients between 2013 and 2015. AB occurred in 41 (42.3%) and 46 (50.5%) patients in the treatment and no treatment groups, respectively. There were no differences in the primary endpoint in the intention-to-treat population (12.2% [5 of 41] in the treatment group vs 8.7% [4 of 46] in the no treatment group; risk ratio, 1.40; 95% confidence interval, 0.40-4.87) or the per-protocol population (13.8% [4 of 29] in the treatment group vs 6.7% [3 of 45] in the no treatment group; risk ratio, 2.07, 95% confidence interval, 0.50-8.58). No differences were found in secondary endpoints, except for antibiotic susceptibility. Fosfomycin (P =.030), amoxicillin-clavulanic (P <.001) resistance, and extended-spectrum ß-lactamase production (P =.044) were more common in KT recipients receiving antibiotic treatment for AB. Conclusions: Antibiotic treatment of AB was not useful to prevent AGP in KT recipients and may increase antibiotic resistance. However, our findings should be regarded with caution, due to the small sample size analyzed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection, A comparative study of sample treatments, DNA extraction methods and real-time PCR assays

  • Abras, Alba|||0000-0003-2002-1186
  • Ballart, Cristina
  • Llovet Pellejero, Maria Teresa|||0000-0001-5746-0348
  • Roig, Carme
  • Gutiérrez, Cristina|||0000-0003-2626-1957
  • Tebar, Silvia
  • Berenguer, Pere
  • Pinazo, María-Jesús
  • Posada, Elizabeth
  • Gascon, Joaquim|||0000-0002-5045-1585
  • Schijman, Alejandro G.|||0000-0001-9805-3415
  • Gállego Culleré, Montserrat|||0000-0002-8143-9773
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
Polymerase chain reaction (PCR) has become a useful tool for the diagnosis of Trypanosoma cruzi infection. The development of automated DNA extraction methodologies and PCR systems is an important step toward the standardization of protocols in routine diagnosis. To date, there are only two commercially available Real-Time PCR assays for the routine laboratory detection of T. cruzi DNA in clinical samples: TCRUZIDNA.CE (Diagnostic Bioprobes Srl) and RealCycler CHAG (Progenie Molecular). Our aim was to evaluate the RealCycler CHAG assay taking into account the whole process. We assessed the usefulness of an automated DNA extraction system based on magnetic particles (EZ1 Virus Mini Kit v2.0, Qiagen) combined with a commercially available Real-Time PCR assay targeting satellite DNA (SatDNA) of T. cruzi (RealCycler CHAG), a methodology used for routine diagnosis in our hospital. It was compared with a well-known strategy combining a commercial DNA isolation kit based on silica columns (High Pure PCR Template Preparation Kit, Roche Diagnostics) with an in-house Real-Time PCR targeting SatDNA. The results of the two methodologies were in almost perfect agreement, indicating they can be used interchangeably. However, when variations in protocol factors were applied (sample treatment, extraction method and Real-Time PCR), the results were less convincing. A comprehensive fine-tuning of the whole procedure is the key to successful results. Guanidine EDTA-blood (GEB) samples are not suitable for DNA extraction based on magnetic particles due to inhibition, at least when samples are not processed immediately. This is the first study to evaluate the RealCycler CHAG assay taking into account the overall process, including three variables (sample treatment, extraction method and Real-Time PCR). Our findings may contribute to the harmonization of protocols between laboratories and to a wider application of Real-Time PCR in molecular diagnostic laboratories associated with health centers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia, a study protocol for a retrospective observational study (BICAR)

  • Gudiol, Carlota|||0000-0003-3095-4422
  • Royo-Cebrecos, Cristina|||0000-0003-2554-4656
  • Tebé, Cristian|||0000-0003-2320-1385
  • Abdala, Edson|||0000-0003-0765-6654
  • Akova, Murat|||0000-0002-6904-9473
  • Álvarez Marín, Rocío|||0000-0002-7101-2514
  • Maestro-de la Calle, Guillermo
  • Cano, Ángela|||0000-0002-5090-7730
  • Cervera, Carlos
  • Clemente, Wanessa T.
  • Martín-Dávila, Pilar|||0000-0002-7469-897X
  • Freifeld, Alison
  • Gómez, Lucia
  • Gottlieb, Thomas
  • Gurguí, Mercè|||0000-0002-0474-3528
  • Herrera, Fabián
  • Manzur, Adriana
  • Maschmeyer, Georg|||0000-0003-2378-2466
  • Meije, Yolanda
  • Montejo, Miguel
  • Peghin, Maddalena|||0000-0002-4640-679X
  • Rodríguez-Baño, Jesús|||0000-0001-6732-9001
  • Ruiz-Camps, Isabel|||0000-0003-3743-2379
  • Sukiennik, Teresa Cristina
  • Carratalà, Jordi|||0000-0003-3209-2563
Bloodstream infection (BSI) due to extended-spectrum β-lactamase-producing Gram-negative bacilli (ESBL-GNB) is increasing at an alarming pace worldwide. Although β-lactam/β-lactamase inhibitor (BLBLI) combinations have been suggested as an alternative to carbapenems for the treatment of BSI due to these resistant organisms in the general population, their usefulness for the treatment of BSI due to ESBL-GNB in haematological patients with neutropaenia is yet to be elucidated. The aim of the BICAR study is to compare the efficacy of BLBLI combinations with that of carbapenems for the treatment of BSI due to an ESBL-GNB in this population. A multinational, multicentre, observational retrospective study. Episodes of BSI due to ESBL-GNB occurring in haematological patients and haematopoietic stem cell transplant recipients with neutropaenia from 1 January 2006 to 31 March 2015 will be analysed. The primary end point will be case-fatality rate within 30 days of onset of BSI. The secondary end points will be 7-day and 14-day case-fatality rates, microbiological failure, colonisation/infection by resistant bacteria, superinfection, intensive care unit admission and development of adverse events. The number of expected episodes of BSI due to ESBL-GNB in the participant centres will be 260 with a ratio of control to experimental participants of 2. The protocol of the study was approved at the first site by the Research Ethics Committee (REC) of Hospital Universitari de Bellvitge. Approval will be also sought from all relevant RECs. Any formal presentation or publication of data from this study will be considered as a joint publication by the participating investigators and will follow the recommendations of the International Committee of Medical Journal Editors (ICMJE). The study has been endorsed by the European Study Group for Bloodstream Infection and Sepsis (ESGBIS) and the European Study Group for Infections in Compromised Hosts (ESGICH).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem

  • Piedra-Carrasco, Núria
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • Calero-Cáceres, William
  • Cornejo-Sánchez, Thais|||0000-0002-1350-0413
  • Brown-Jaque, Maryury
  • Mir-Cros, Alba|||0000-0003-4827-9824
  • Muniesa, Maite|||0000-0001-5549-1394
  • González-López, Juanjo|||0000-0003-2419-5909
The increasing resistance to carbapenems is an alarming threat in the fight against multiresistant bacteria. The dissemination properties of antimicrobial resistance genes are supported by their detection in a diverse population of bacteria, including strains isolated from the environment. The objective of this study was to investigate the presence of carbapenemase-producing Enterobacteriaceae (CPE) collected from a river ecosystem in the Barcelona metropolitan area (Spain). Identification of β-lactamases and other resistance determinants was determined as was the antimicrobial susceptibility profile. Moreover, screening of virulence factors, plasmid addiction systems, plasmid partition systems and replicon typing was performed. The results identified 8 isolates belonging to different species (Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella oxytoca, Raoultella ornithinolytica). The most prevalent enzyme was KPC-2 (n = 6), followed by VIM-1 (n = 2) and IMI-2 (n = 1), whereas no OXA-48-type was detected. In addition, one strain was positive for both KPC-2 and VIM-1 enzymes. All the carbapenemase-encoding plasmids carried at least one plasmid addiction or partition system, being vagCD and parAB the most frequently detected, respectively. E. coli and K. pneumoniae isolates carried a low number of virulence-associated factors and none of the detected clones has previously been identified in the clinical setting. These findings support the high dissemination potential of the carbapanemase-encoding genes and reinforce the idea that the environment is another reservoir that may play an important role in the capture, selection and dissemination of carbapenem resistance genes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

First insights into the pleiotropic role of vrf (yedF), a newly characterized gene of Salmonella Typhimurium

  • Ballesté-Delpierre, Clara|||0000-0001-8589-2519
  • Fernandez-Orth, Dietmar|||0000-0002-1237-3192
  • Ferrer-Navarro, Mario|||0000-0001-9990-914X
  • Díaz-Peña, Ramón
  • Odena-Caballol, Antonia
  • Oliveira, Eliandre
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • Vila Estapé, Jordi|||0000-0002-8025-3926
Salmonella possesses virulence determinants that allow replication under extreme conditions and invasion of host cells, causing disease. Here, we examined four putative genes predicted to encode membrane proteins (ydiY, ybdJ, STM1441 and ynaJ) and a putative transcriptional factor (yedF). These genes were identified in a previous study of a S. Typhimurium clinical isolate and its multidrug-resistant counterpart. For STM1441 and yedF a reduced ability to interact with HeLa cells was observed in the knock-out mutants, but an increase in this ability was absent when these genes were overexpressed, except for yedF which phenotype was rescued when yedF was restored. In the absence of yedF, decreased expression was seen for: i) virulence-related genes involved in motility, chemotaxis, attachment and survival inside the host cell; ii) global regulators of the invasion process (hilA, hilC and hilD); and iii) factors involved in LPS biosynthesis. In contrast, an increased expression was observed for anaerobic metabolism genes. We propose yedF is involved in the regulation of Salmonella pathogenesis and contributes to the activation of the virulence machinery. Moreover, we propose that, when oxygen is available, yedF contributes sustained repression of the anaerobic pathway. Therefore, we recommend this gene be named vrf, for virulence-related factor.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex

  • Rubio, Marc|||0000-0002-4811-0642
  • March, Francesca
  • Garrigó i Fullola, Montserrat
  • Moreno, Carmen|||0000-0003-0541-4846
  • Español, Montserrat|||0000-0002-2365-5750
  • Coll Figa, Pedro|||0000-0003-1782-9782
Clarithromycin was considered the cornerstone for the treatment of Mycobacterium abscessus complex infections. Genetic resistance mechanisms have been described and many experts propose amikacin as an alternative. Nevertheless, clarithromycin has several advantages; therefore, it is necessary to identify the non-functional erm(41) allele to determine the most suitable treatment. The aims of this study were to characterize the molecular mechanisms of clarithromycin resistance in a collection of Mycobacterium abscessus complex isolates and to verify the relationship between these mechanisms and the antibiogram. Clinical isolates of M. abscessus complex (n = 22) from 16 patients were identified using four housekeeping genes (rpoB, secA1, sodA and hsp65), and their genetic resistance was characterized by studying erm(41) and rrl genes. Nine strains were recovered from the clinical isolates and subjected to E-test and microdilution clarithromycin susceptibility tests, with readings at 3, 7 and 14 days. We classified 11/16 (68.8%) M. abscessus subsp. abscessus, 4/16 (25.0%) M. abscessus subsp. bolletii, and 1/16 (6.3%) M. abscessus subsp. massiliense. T28 erm(41) allele was observed in 8 Mycobacterium abscessus subps. abscessus and 3 Mycobacterium abscessus subsp. bolletii. One strain of M. abscessus subsp. bolletii had an erm(41) gene truncated and was susceptible to clarithromycin. No mutations were observed in rrl gene first isolates. In three patients, follow-up of initial rrl wild-type strains showed acquired resistance. Most clinical isolates of M. abscessus complex had inducible resistance to clarithromycin and total absence of constitutive resistance. Our findings showed that the acquisition of resistance mutations in rrl gene was associated with functional and non-functional erm(41) gene. Caution is needed when using erm(41) sequencing alone to identify M. abscessus subspecies. This study reports an acquired mutation at position 2057 of rrl gene, conferring medium-low clarithromycin constitutive resistance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain

  • Fernández-Martínez, Marta
  • Miró, Elisenda|||0000-0003-2781-6926
  • Ortega, Adriana|||0000-0002-8895-6810
  • Bou, German|||0000-0001-8837-0062
  • González, Juan José
  • Oliver, Antonio|||0000-0001-9327-1894
  • Pascual Hernández, Álvaro|||0000-0002-8672-5891
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Oteo-Iglesias, Jesús|||0000-0003-3327-8263
  • Martínez-Martínez, Luis
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
The activity of eight aminoglycosides (amikacin, apramycin, arbekacin, gentamicin, kanamycin, neomycin, netilmicin and tobramycin) against a collection of 257 amoxicillin/clavulanic acid (AMC)-resistant Escherichia coli isolates was determined by microdilution. Aminoglycoside resistance rates, the prevalence of aminoglycoside-modifying enzyme (AME) genes, the relationship between AME gene detection and resistance phenotype to aminoglycosides, and the association of AME genes with mechanisms of AMC resistance in E. coli isolates in Spain were investigated. Aminoglycoside-resistant isolates were screened for the presence of genes encoding common AMEs [aac(3)-Ia, aac(3)-IIa, aac(3)-IVa, aac(6')-Ib, ant(2')-Ia, ant(4')-IIa and aph(3')-Ia] or 16S rRNA methylases (armA, rmtB, rmtC and npmA). In total, 105 isolates (40.9%) were resistant to at least one of the aminoglycosides tested. Amikacin, apramycin and arbekacin showed better activity,with MIC90 values of 2 mg/L (arbekacin) and 8 mg/L (amikacin and apramycin). Kanamycin presented the highest MIC90 (128 mg/L). The most common AME gene was aac(6')-Ib (36 strains; 34.3%), followed by aph(3')-Ia (31 strains; 29.5%), ant(2')-Ia (29 strains; 27.6%) and aac(3)-IIa (23 strains; 21.9%). aac(3)-Ia, aac(3)-IVa, ant(4')-IIa and the four methylases were not detected. The ant(2')-Ia gene was usually associated with OXA-1 [21/30; 70%], whilst 23/25 (92%) strains producing CTX-M-15 had the aac(6')-Ib gene. The most prevalent AME gene was aac(6')-Ib (18/41; 44%) in nosocomial isolates, whilst ant(2')-Ia and aph(3')-Ia genes (20/64; 31%) were more frequent in strains of community origin. In 64.6% isolates the phenotypic profile correlated with the presence of commonly encountered AMEs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibitor-resistant TEM- And OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates

  • Oteo-Iglesias, Jesús|||0000-0003-3327-8263
  • González, Juan José
  • Ortega, Adriana|||0000-0002-8895-6810
  • Quintero Zarate, Julieth Nàtalia
  • Bou, German|||0000-0001-8837-0062
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Conejo, M. Carmen
  • Martínez-Martínez, Luis
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Oliver, Antonio|||0000-0001-9327-1894
  • Bartolomé Comas, Rosa Maria|||0000-0001-7655-6089
  • Campos, José
In a previous prospective multicenter study in Spain, we found that OXA-1 and inhibitor-resistant TEM (IRT) β-lactamases constitute the most common plasmid-borne mechanisms of genuine amoxicillin-clavulanate (AMC) resistance in Escherichia coli. In the present study, we investigated the population structure and virulence traits of clinical AMC-resistant E. coli strains expressing OXA-1 or IRT and compared these traits to those in a control group of clinical AMC-susceptible E. coli isolates. All OXA-1-producing (n = 67) and IRT-producing (n = 45) isolates were matched by geographical and temporal origin to the AMC-susceptible control set (n = 56). We performed multilocus sequence typing and phylogenetic group characterization for each isolate and then studied the isolates for the presence of 49 virulence factors (VFs) by PCR and sequencing. The most prevalent clone detected was distinct for each group: group C isolates of sequence type (ST) 88 (C/ST88) were the most common in OXA-1 producers, B2/ST131 isolateswere the most common in IRT producers, and B2/ST73 isolates were the most common in AMC-susceptible isolates. The median numbers of isolates per ST were 3.72 in OXA-1 producers, 2.04 in IRT producers, and 1.69 in AMC-susceptible isolates; the proportions of STs represented by one unique isolate in each group were 19.4%, 31.1%, and 48.2%, respectively. The sum of all VFs detected, calculated as a virulence score, was significantly higher in AMC-susceptible isolates than OXA-1 and IRT producers (means, 12.5 versus 8.3 and 8.2, respectively). Our findings suggest that IRT- and OXA-1-producing E. coli isolates resistant to AMC have a different and less diverse population structure than AMC-susceptible clinical E. coli isolates. The AMC-susceptible population also contains more VFs than AMC-resistant isolates.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) in Latin-American migrants in Barcelona (Spain)

  • Abras, Alba|||0000-0003-2002-1186
  • Gállego Culleré, Montserrat|||0000-0002-8143-9773
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Juiz, Natalia A.
  • Ramírez, Juan Carlos
  • Cura, Carolina I.
  • Tebar, Silvia
  • Fernández-Arévalo, Anna|||0000-0003-4925-7184
  • Pinazo, María-Jesus
  • de la Torre, Leonardo
  • Posada, Elizabeth
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Espinal, Paula|||0000-0002-1014-8936
  • Ballart, Cristina
  • Portús, Montserrat
  • Gascon, Joaquim|||0000-0002-5045-1585
  • Schijman, Alejandro G.|||0000-0001-9805-3415
Trypanosoma cruzi, the causative agent of Chagas disease, is divided into six Discrete Typing Units (DTUs): TcI-TcVI. We aimed to identify T. cruzi DTUs in Latin-American migrants in the Barcelona area (Spain) and to assess different molecular typing approaches for the characterization of T. cruzi genotypes. Seventy-five peripheral blood samples were analyzed by two real-time PCR methods (qPCR) based on satellite DNA (SatDNA) and kinetoplastid DNA (kDNA). The 20 samples testing positive in both methods, all belonging to Bolivian individuals, were submitted to DTU characterization using two PCR-based flowcharts: multiplex qPCR using TaqMan probes (MTq-PCR), and conventional PCR. These samples were also studied by sequencing the SatDNA and classified as type I (TcI/III), type II (TclI/IV) and type I/II hybrid (TcV/VI). Ten out of the 20 samples gave positive results in the flowcharts: TcV (5 samples), TcII/V/VI (3) and mixed infections by TcV plus TclI (1) and TcV plus Tcll/VI (1). By SatDNA sequencing, we classified the 20 samples, 19 as type I/II and one as type I. The most frequent DTU identified by both flowcharts, and suggested by SatDNA sequencing in the remaining samples with low parasitic loads, TcV, is common in Bolivia and predominant in peripheral blood. The mixed infection by TcV-TclI was detected for the first time simultaneously in Bolivian migrants. PCR-based flowcharts are very useful to characterize DTUs during acute infection. SatDNA sequence analysis cannot discriminate T. cruzi populations at the level of a single DTU but it enabled us to increase the number of characterized cases in chronically infected patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization of the Genetic Environment of the blaVEB-4 Gene, Associated with a Transposable Region in a Proteus mirabilis Clinical Isolate

  • Espinal, Paula|||0000-0002-1014-8936
  • Miró, Elisenda|||0000-0003-2781-6926
  • Ramoneda, Laia
  • Flores, Manel
  • Rivera, Alba|||0000-0002-9709-6162
  • Coll Figa, Pedro|||0000-0003-1782-9782
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
Proteus mirabilis is the second most common cause of urinary tract infections and is also an important cause of nosocomial infections. TEM-type and CTX-M-type extended-spectrum β-lactamases (ESBLs) are the most widely distributed in this bacterial species, but minor ESBLs such as the VEB-type have also been identified. The aim of this study was to analyze the genetic environment of the blaVEB-4 gene found in a P. mirabilis clinical isolate recovered in Spain. P. mirabilis N2231 showed resistance to penicillins, cephalosporins, and aminoglycosides, remaining susceptible to imipenem, cefoxitin, β-lactamases inhibitors, and quinolones. Southern blot analysis revealed that blaVEB-4 was located in the chromosome. Analysis of the blaVEB-4 genetic context revealed a 15 kb segment 98% identical to the multidrug resistance (MDR) region of a Salmonella genomic island 1 (SGI1), which included a class 1 integron belonging to the In104 family, previously described in blaVEB-6-producing P. mirabilis VB1248. blaVEB-4 was surrounded by repeat elements, transposon Tn1721, and located on a class 1 integron containing aacA4-aadB-dfrA1-orfC genes. The blaVEB-4 gene was inserted in a complex structure of a class 1 integron, which is part of an MDR region of an SGI1, possibly involved in the mobilization of the gene and homologous recombination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Bacteriophages in clinical samples can interfere with microbiological diagnostic tools

  • Brown-Jaque, Maryury
  • Muniesa, Maite|||0000-0001-5549-1394
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
Bacteriophages are viruses that infect bacteria, and they are found everywhere their bacterial hosts are present, including the human body. To explore the presence of phages in clinical samples, we assessed 65 clinical samples (blood, ascitic fluid, urine, cerebrospinal fluid, and serum). Infectious tailed phages were detected in >45% of ascitic fluid and urine samples. Three examples of phage interference with bacterial isolation were observed. Phages prevented the confluent bacterial growth required for an antibiogram assay when the inoculum was taken from an agar plate containing lysis plaques, but not when taken from a single colony in a phage-free area. In addition, bacteria were isolated directly from ascitic fluid, but not after liquid enrichment culture of the same samples, since phage propagation lysed the bacteria. Lastly, Gram-negative bacilli observed in a urine sample did not grow on agar plates due to the high densities of infectious phages in the sample.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Faecal phageome of healthy individuals, Presence of antibiotic resistance genes and variations caused by ciprofloxacin treatment

  • Fernandez-Orth, Dietmar|||0000-0002-1237-3192
  • Miró, Elisenda|||0000-0003-2781-6926
  • Brown-Jaque, Maryury
  • Rodríguez-Rubio, Lorena|||0000-0002-7846-4791
  • Espinal, Paula|||0000-0002-1014-8936
  • Rodríguez-Navarro, Judith|||0000-0002-2855-254X
  • González-López, Juanjo|||0000-0003-2419-5909
  • Muniesa, Maite|||0000-0001-5549-1394
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
Objectives: Antimicrobial resistance genes (ARGs) can be transferred by means of mobile genetic elements, which play a critical role in the dissemination of resistance in the bacterial community. ARG transmission within mobile genetic elements has been reported in plasmids and transposons but less frequently in bacteriophages. Here, the bacteriophage fraction of seven human faecal samples was purified and deep-sequenced to detect the presence of ARGs in the phage particles. Methods: Seven faecal samples (five from healthy individuals and two from a patient before and after receiving ciprofloxacin treatment) were used to extract phage DNA, which was purified and then sequenced in a MiSeq (Illumina). Generated reads were checked for quality and assembled, and then the generated contigs analysed with Kraken, PHASTER, VirSorter and Prokka. Some genes were also validated by quantitative PCR. Results: Analysis of the purified phage DNA by Kraken identified from 4 to 266 viruses in the samples. The viral fraction corresponded mainly to the order Caudovirales, including phages from the Siphoviridae and Myoviridae families. Bacterial genes associated with antimicrobial resistance were detected in the viral DNA, as confirmed by quantitative PCR. Higher densities of ARG-carrying phage particles were observed in the post- versus preciprofloxacin treatment sample. Conclusions: The finding of ARGs in phage particles supports the description of phages as mobile elements contributing to the dissemination of bacterial antibiotic resistance and suggests ciprofloxacin treatment may play a role in the release of ARG-carrying particles, thereby increasing resistance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Activity of ceftazidime-avibactam against clinical and isogenic laboratory Pseudomonas aeruginosa isolates expressing combinations of most relevant β-lactam resistance mechanisms

  • Torrens, Gabriel
  • Cabot, Gabriel|||0000-0002-6452-9945
  • Ocampo-Sosa, Alain A.|||0000-0002-9104-3115
  • Conejo, M. Carmen
  • Zamorano, Laura
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Pascual Leone, Álvaro|||0000-0001-8975-0382
  • Martínez-Martínez, Luis
  • Oliver, Antonio|||0000-0001-9327-1894
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem against a collection of 190 Pseudomonas aeruginosa clinical isolates recovered from a multicenter study of bloodstream infections. The addition of avibactam increased ceftazidime susceptibility in the complete collection of strains (64.7% to 91.1%) and particularly among subsets of isolates showing AmpC hyperproduction (10.9% to 76.1%) or multidrug resistance (MDR) profiles (27% to 77.8%). The MICs of ceftazidime-avibactam, in contrast with those of ceftazidime or meropenem, remained at ≤4 μg/ml for a panel of 16 P. aeruginosa PAO1 isogenic mutants expressing multiple combinations of the most relevant β-lactam resistance mechanisms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of commensal and clinical isolates for diversity of plasmids in Escherichia coli and Klebsiella pneumoniae

  • Rodríguez-Navarro, Judith|||0000-0002-2855-254X
  • Miró, Elisenda|||0000-0003-2781-6926
  • Brown-Jaque, Maryury
  • Hurtado, Juan Carlos
  • Moreno Mingorance, Albert|||0000-0002-3073-5046
  • Muniesa, Maite|||0000-0001-5549-1394
  • González-López, Juanjo|||0000-0003-2419-5909
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Espinal, Paula|||0000-0002-1014-8936
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
In this study, the plasmid content of clinical and commensal strains was analyzed and compared. The replicon profile was similar in both populations, except for L, M, A/C, and N (detected only in clinical strains) and HI1 (only in commensal strains). Although I1 and F were the most frequent replicons, only IncI1, sequence type 12 (ST12) was associated with blaCMY-2 in both populations. In contrast, the widespread resistant IncF plasmids were not linked to a single epidemic plasmid.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibiotic resistance genes in phage particles isolated from human faeces and induced from clinical bacterial isolates

  • Brown-Jaque, Maryury
  • Calero-Cáceres, William
  • Espinal, Paula|||0000-0002-1014-8936
  • Rodríguez-Navarro, Judith|||0000-0002-2855-254X
  • Miró, Elisenda|||0000-0003-2781-6926
  • González-López, Juanjo|||0000-0003-2419-5909
  • Cornejo-Sánchez, Thais|||0000-0002-1350-0413
  • Hurtado, Juan Carlos
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Muniesa, Maite|||0000-0001-5549-1394
Phage particles have emerged as elements with the potential to mobilise antibiotic resistance genes (ARGs) in different environments, including the intestinal habitat. This study aimed to determine the occurrence of ARGs in phage particles present in faecal matter and induced from strains isolated from faeces. Nine ARGs (blaTEM, blaCTX-M-1 group, blaCTX-M-9 group, blaOXA-48, qnrA, qnrS, mecA, sul1 and armA) were quantified by qPCR in the phage DNA fractions of 150 faecal samples obtained from healthy individuals who had not received antibiotic treatment or travelled abroad in the 3 months prior to sample collection. On the suspicion that the detected particles originated from bacterial flora, 82 Escherichia coli and Klebsiella pneumoniae isolates possessing at least one identified ARG (blaTEM, blaCTX-M-1 group, blaCTX-M-9 group, armA, qnrA, qnrS and sul1) were isolated and their capacity to produce phage particles carrying these ARGs following induction was evaluated. Of 150 samples, 72.7% were positive for at least one ARG, with blaTEM and blaCTX-M-9 group being the most prevalent and abundant. Of the 82 isolates, 51 (62%) showed an increase in the number of copies of the respective ARG in the phage fraction following induction, with blaTEM, blaCTX-M-1 group, blaCTX-M-9 group and sul1 being the most abundant. Phages induced from the isolates were further purified and visualised using microscopy and their DNA showed ARG levels of up to 1010 gene copies/mL. This study highlights the abundance of phage particles harbouring ARGs and indicates that bacterial strains in the intestinal habitat could be source of these particles.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Quorum sensing network in clinical strains of A. baumannii, AidA is a new quorum quenching enzyme

  • López Díaz, María|||0000-0003-4217-3295
  • Mayer, Celia|||0000-0002-6981-6601
  • Fernández-García, Laura|||0000-0002-8531-6105
  • Blasco, Lucía|||0000-0002-4039-4142
  • Muras, Andrea|||0000-0003-1603-9762
  • Ruiz, Federico M.|||0000-0002-0385-7777
  • Bou, German|||0000-0001-8837-0062
  • Otero, Ana|||0000-0002-3315-5709
  • Tomas, Maria|||0000-0003-4501-0387
  • Rodríguez-Baño, Jesús|||0000-0001-6732-9001
  • Pascual Hernández, Álvaro|||0000-0002-8672-5891
  • Fernández-Cuenca, Felipe
  • Pachón, Jerónimo|||0000-0002-8166-5308
  • Cisneros, José Miguel|||0000-0001-5001-672X
  • Garnacho, José
  • Gutierrez Pizarraya, Antonio
  • Márquez Vácaro, Juan Antonio
  • Martínez Martínez, Luis
  • Cano, María Eliecer
  • Fariñas, M.Carmen
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Sánchez Porto, Antonio|||0000-0001-6906-7017
  • Esteban Meruendano, Gloria
  • Barbeyto Vales, Luis
  • Casas Ciria, Javier|||0000-0001-9820-261X
  • Vallejo, Luis
  • Fernández Pérez, Begoña
  • Villar-Chao, José Carlos
  • Padilla Ortega, Belén
  • Cercenado, Emilia|||0000-0002-5279-3773
  • García Irure, José Javier
  • del Arco Jiménez, Alfonso|||0000-0002-5432-4591
  • Gimeno Cardona, Concepción
  • Valía, Juan Carlos
  • Tormo, Nuria|||0000-0002-4514-7730
  • Abril López de Medrano, Vicente
  • Rifa, Josefina
  • Martinez Garcia, Maria Jesus
  • Vilaró Pujals, Joseph
  • Navarro Aguirre, Marian
  • Vilamala, Ana
  • Jiménez Alfaro, José Antonio
  • Reviejo Jaca, Carlos
  • Marín Casanova, Pilar
  • Guerreo, Francisca
  • Shaw, Evelyn|||0000-0002-1882-1259
  • Plasencia, Virginia
  • Nebreda Mayoral, Teresa
  • Fernández Calavia, María José
  • García de Cruz, Susana
  • Aldea Mansilla, Carmen
  • Merino de Lucas, Esperanza|||0000-0003-3854-4874
  • Zorraquino, Alfredo
  • Reus, Sergio|||0000-0002-3320-9754
  • Garduno Eseverri, Eugenio
  • López Sánchez, Luis
  • Fleites Gutiérrez, Ana
  • Rodríguez Guardado, Azucena|||0000-0002-4279-2179
  • Moreno, Alfonso
  • García-Arenzana Anguera, José María
  • López Palmero, Serafín
  • Rodríguez Maresca, Manuel
  • García Garrote, Fernando
  • Varela Otero, José
  • Alonso, María del Pilar
  • Vidal Verdú, Elisa
  • Rodríguez López, Fernando
  • Pardo Sánchez, Fernanda
  • Ferrer Vizoso, E.
  • Regueiro Garcia, B.
  • Gurguí, Mercè|||0000-0002-0474-3528
  • Pericas, Roser
  • Pomar, Virginia|||0000-0002-8473-5834
  • Olaechea Astigarraga, Pedro María
  • Ayarza Igartua, Rafael
  • Maciá Romero, María Dolores
  • Ruiz de Gopegui, Enrique
  • Sánchez Romero, María Isabel
  • García Mata, Jesús
  • Goyanes, María Jesús
  • Morales Mateos, Cristina
  • Hernández Quero, José
  • Escobar Lara, Trinidad
  • Ballester, Frederic
  • Iftimie, Simona Mihaela|||0000-0003-0714-8414
  • Pujol Bajador, Isabel
  • Galán Navarro, María Isabel
  • Cádiz Gurrea, María de la Luz|||0000-0002-2613-4889
  • Amores Antequera, Carmen
  • Gómez, Montserrat
  • Cantudo, Purificación
  • Martí Salas, Carmina
  • Cuquet, Jordi
  • Moreno Flores, Antonio
  • Anibarro, Luis|||0000-0001-8790-6320
  • Hernando Real, Susana
  • Carrero González, Pablo A.
  • Pallarés González, María Angeles|||0000-0003-2237-9501
  • Rodríguez Fernández, Sergio
  • Pujol, Miquel|||0000-0002-6475-6208
  • Tubau, Fe|||0000-0002-6416-6451
  • Nuno Alvarez, Enrique
  • Ortega Torres, María
  • Giner Almaraz, Salvador
  • Roca Castelló, María Rosa
  • Castillo, Manuela
  • Hortelano, Elena
  • Chaves Sánchez, Fernando
  • García Reyne, Ana
  • Horcajada, Juan Pablo|||0000-0001-9873-5459
  • Segura, Concha
  • Sierra Dorado, Gema
  • Yano Escudero, Raquel
  • Dorta-Hung, María Elena
  • Cristóbal del Rosario, Q.
Acinetobacter baumannii is an important pathogen that causes nosocomial infections generally associated with high mortality and morbidity in Intensive Care Units (ICUs). Currently, little is known about the Quorum Sensing (QS)/Quorum Quenching (QQ) systems of this pathogen. We analyzed these mechanisms in seven clinical isolates of A. baumannii. Microarray analysis of one of these clinical isolates, Ab1 (A. baumannii ST-2-clon-2010), previously cultured in the presence of 3-oxo-C12-HSL (a QS signalling molecule) revealed a putative QQ enzyme (α/β hydrolase gene, AidA). This QQ enzyme was present in all nonmotile clinical isolates (67% of which were isolated from the respiratory tract) cultured in nutrient depleted LB medium. Interestingly, this gene was not located in the genome of the only motile clinical strain growing in this medium (A. baumannii strain Ab421-GEIH-2010 [Ab7], isolated from a blood sample). The AidA protein expressed in E. coli showed QQ activity. Finally, we observed downregulation of the AidA protein (QQ system attenuation) in the presence of HO (ROS stress). In conclusion, most of the A. baumannii clinical strains were not surface motile (84%) and were of respiratory origin (67%). Only the pilT gene was involved in surface motility and related to the QS system. Finally, a new QQ enzyme (α/β hydrolase gene, AidA protein) was detected in these strains.